Category: EQS Newswire

EQS via SeaPRwire.com / 29/06/2026 / 10:32 UTC+8 Global survey shows fragmented contract data is becoming a major barrier to enterprise AI adoption, automation, and operational trust Lehi, Utah - June 29, 2026 - (SeaPRwire) - Sirion, the global leader in AI-native contract lifecycle management (CLM), in collaboration with World Commerce & Contracting (WorldCC), today released a new research report titled: Trusted Contract Data: From Repository to System of Record (SOR). As enterprises accelerate AI adoption, the findings reveal a growing divide between organizations that merely store contracts and those that can trust, operationalize and act oncontract data across the enterprise. The report* comprises responses and insights from more than 170 enterprises worldwide, including legal, procurement, and IT leaders. The research suggests that many enterprise AI initiatives may be constrained not by model capability, but by fragmented and untrusted contract data foundations. "GenAI is exposing a hard truth across enterprises: AI is only as reliable as the underlying data foundation," said Ajay Agrawal, Co-Founder and CEO, Sirion. Most organizations still manage contracts as disconnected documents spread across repositories, shared drives, and siloed systems. That model breaks down in an AI-driven enterprise. Contracting now requires a trusted System of Record that can transform legal language into structured, connected, operational data. Without that foundation, AI cannot reliably drive decisions, automation, or enterprise-scale execution."While most organizations now have a place to store executed contracts, the report highlights a more important gap: far fewer have established a true contract SOR, capable of capturing what was agreed to, where it applies, what obligations and entitlements follow, and whether the business can confidently act on that information. "Change management remains the most under-considered element in contracting transformation, yet it is often the determining factor between success and failure," noted Leandro Doca, VP, Head of CCM for Americas at Capgemini, in the survey. Key Findings from the Survey: Contract data remains deeply fragmented: In Europe and Oceania, 38% of organizations report that contracts are split across multiple repositories. Shared drives remain a primary storage location outside of a central repository, used by 71% of respondents in North America, 78% in Europe, and 71% in Oceania. Centralized storage does not equal trusted data: Only 27% of organizations globally store all executed contracts exclusively in CLM, with the majority operating in fragmented environments. Integration maturity remains extremely low: 54% of organizations report having no automated data flow between systems, while only 9% have bidirectional synchronization that keeps contract data consistently updated across platforms. Maturity varies significantly by industry: Banking and Financial Services, along with IT/Technology Services and Energy/Oil & Gas, show the highest levels of centralized CLM storage. Banking/Financial Services leads at 50%, while IT (Technology-Software) is at 33%, and Energy/Oil & Gas is at 25%. AI ambition is accelerating faster than data readiness: 42% of organizations are actively adopting or implementing AI within contracting processes. Yet concerns around data quality, integration, governance, and trust remain among the biggest barriers to progress. The barrier is no longer AI capability. It is trusted data, connected systems, and operational governance. "This report is a warning against mistaking storage for control," said Sally Guyer, CEO, WorldCC. "Organizations may have digitized their contract archives, but that does not mean they have trusted contract data. In today's market, organizations need to know what was agreed, what has changed, what action is required, and whether the business can rely on that information. Trusted contract data is now the foundation for better execution. The organizations that move forward will be those that clean up their data, connect their systems, widen access, and define clear ownership. They will not rely on AI to fix weak foundations. They will use AI to amplify strong ones." The report also highlights the operational consequences of disconnected contract data. Without a trusted and connected SOR, enterprises remain dependent on manual interpretation, fragmented repositories, and institutional knowledge. The result is slower decision-making, weaker visibility into obligations and entitlements, highervalue leakage, and lower confidence in AI-generated outputs. Trusted contract data: From Repository to System of Record is now available from Sirion and WorldCC. Download the report: https://info.worldcc.com/trusted-contract-data *The survey was conducted between 13 February and 10 April 2026 with 170 respondents. About WorldCC World Commerce & Contracting (WorldCC) is a global non-profit association dedicated to improving trading relationships and commercial effectiveness. With more than 80,000 members worldwide, WorldCC provides research, standards, training, and resources that enable organizations to achieve better commercial and contracting outcomes. About Sirion Sirion is the world's leading AI-native CLM platform, pioneering the application of agentic AI to help enterprises transform the way they store, create, and manage contracts. The platform's extraction, conversational experience, and AI-enhanced negotiation capabilities have revolutionized contracting across enterprise teams–from legal and procurement to sales and finance. The world's most valuable brands trust Sirion to manage 7M+ contracts worth nearly $800B and relationships with 1M+ suppliers and customers in 100+ languages. Leading analysts such as Gartner, IDC, and Spend Matters have consistently recognized Sirion as a leader in CLM for its focus on category-leading innovation. For more information, visit www.sirion.ai Media contact: For WorldCC Kate Hodgins Head of Marketing & Communications khodgins@worldcc.com For Sirion Bodhi Thakur Head of Brand and Comms bodhi.thakur@sirionlabs.com 29/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 25/06/2026 / 18:12 UTC+8 On 24 June, Micot Pharma-B (02335.HK) officially listed on the Hong Kong Stock Exchange, becoming the first innovative drug company under Chapter 18A of the Hong Kong Listing Rules with a peptide core technology platform — the long-awaited “Hong Kong’s First Peptide Innovative Drug Stock.” On its first trading day, its stock price performed strongly, closing at HK$36.90, more than double the offering price of HK$18.20, with its market capitalization quickly surpassing HK$10 billion. Prior to listing, the Hong Kong public offering was oversubscribed by more than 1,000 times, and the international placement was also oversubscribed, reflecting a recovery in market appetite for differentiated innovative drugs. As Hong Kong's first listed peptide-innovative drug company, Micot Pharma has spent over a decade focusing on dual- and multi-functional peptide innovative drugs, building a peptide drug portfolio spanning kidney, metabolic, cardiovascular, and cerebrovascular diseases. The company has self-developed a comprehensive pipeline consisting of one core product and six key candidates, all seven of which have entered clinical stages, with six filing simultaneously in both the PRC and the U.S., making it the Chinese company with the most innovative peptide drugs in clinical stages. MT1013: A Differentiated Pipeline Recognized by International Academic Institutions, with a Clear Commercialization Path Micot Pharma's core product, MT1013, is a dual-target receptor agonist polypeptide that simultaneously targets the CaSR and the OGP receptor. It primarily targets chronic kidney disease-secondary hyperparathyroidism (CKD-SHPT), a common complication of chronic kidney disease. The global patient population is projected to reach 188 million by 2030, with the related drug market in Chinese Mainland valued at approximately RMB 5 billion. This condition is not merely an elevation of parathyroid hormone (iPTH), but a systemic issue involving calcium-phosphorus imbalance, abnormal bone metabolism, and increased cardiovascular risk. Current mainstream drugs, such as cinacalcet and etelcalcetide, primarily lower iPTH but still have limitations in areas including blood calcium reduction, gastrointestinal side effects, improvements in bone metabolism, and overall target achievement rates. MT1013's differentiation lies in its dual-target synergy: it lowers iPTH through CaSR receptor while promoting bone metabolism improvement through OGP-related mechanisms. It aims to simultaneously improve multiple indicators, including iPTH, blood calcium, blood phosphorus, and bone metabolism. According to Phase II head-to-head clinical data disclosed by the company, MT1013 demonstrated a 2.2- to 2.5-fold higher comprehensive target achievement rate for iPTH, serum calcium, and serum phosphorus compared with etelcalcetide, while also significantly reducing FGF23 levels, a biomarker directly linked to cardiovascular risk. At the same time, MT1013's clinical value has also received substantial recognition from leading international academic institutions. Its research data was accepted as a "Late-Breaking" at the American Society of Nephrology (ASN) Annual Meeting, the highest-level recognition for innovative therapies on the world's most influential academic stage in nephrology. Currently, MT1013's Phase III clinical trial has completed patient enrolment. The company expects to submit an NDA application in early 2027 and achieve commercialization in early 2028. In 2026, the company entered into an exclusive commercialization partnership agreement with Everest Medicines (stock code: 1952.HK), covering China and the Asia-Pacific region (excluding Japan). The total upfront and milestone payments could reach up to RMB 1.24 billion, with RMB 200 million already received. XTL6001: Not Just Another GLP-1, but an Extension into Cardio-Renal-Metabolic Territory If MT1013 serves as the near-term commercialization milestone, XTL6001 would represent Micot Pharma's second growth driver. XTL6001 is the world's first and only GLP-1R/GCGR/MasR tri-target agonist to have received IND approvals in both the PRC and the U.S. Compared with traditional GLP-1 or GLP-1/GIP dual-target drugs, its differentiation goes beyond "three targets". By introducing MasR, it brings significant hepatic and renal protective advantages. Activation of this pathway exerts anti-inflammatory, anti-fibrotic, and vasodilatory effects that directly address key mechanisms in CKD progression. This naturally extends its indication from weight loss to CKD with proteinuria and other diseases, addressing the shortcomings of single-target GLP-1 drugs in renal benefits. Additionally, XTL6001 offers multiple metabolic regulatory functions such as fat reduction and muscle preservation, providing patients with an integrated treatment approach from body composition optimization to target organ protection. Its indications extend from weight loss to CKD with proteinuria, MASH, and other conditions, targeting the renal disease gaps that GLP-1 drugs cannot cover. Preclinical studies show that XTL6001 achieves a greater reversal of fatty liver than tirzepatide and can further reduce the urine albumin-to-creatinine ratio (UACR) by an additional 15%–20% compared with finerenone. According to the company disclosure, the Phase I clinical trial of XTL6001 has been completed. MT1002 and MT200605: First and Only in the World In addition to MT1013 and XTL6001, Micot Pharma has also built two high-potential product candidates, MT1002 and MT200605, targeting stroke and coronary heart disease. These are among the most burdensome cardiovascular and cerebrovascular conditions globally, yet remain areas with a severe shortage of innovative treatments. MT1002 is a coagulation factor II and GP IIb/IIIa dual-target peptide antagonist, primarily designed for clinical needs in anticoagulation and anti-thrombosis. Using a single molecule, it could address the existing challenge of balancing bleeding and ischemia in multi-drug combination regimens. MT200605 targets acute ischemic stroke (AIS) through dual mechanisms of promoting nerve regeneration and scavenging oxygen-free radicals, thereby blocking the cascade of pathological damage after AIS via two pathways. MT1002 is currently in Phase II clinical trials in both the U.S. and the PRC, demonstrating good efficacy and safety across different patient populations and dose levels. Meanwhile, MT200605 has completed patient enrolment for Phase II clinical trials in the PRC, with Phase I clinical studies demonstrating favorable safety and tolerability profile. Dual Endorsement from State-Owned and Industrial Capital: A Clearer Commercialization Path Micot Pharma brought in Qiyuan Hong Kong, Everest Medicines, and Summit Capital as cornerstone investors for this IPO, creating a structure involving local government funds, industrial capital, and professional healthcare investment institutions. Among them, Qiyuan Hong Kong represents support from Shaanxi provincial state-owned capital; Summit Capital represents recognition from professional healthcare investment; and Everest Medicines carries the most direct industrial significance. Everest Medicines had already signed an exclusive commercialization agreement with the company for MT1013. Its participation as a cornerstone investor in this IPO signifies the relationship has been upgraded from a purely commercial partnership to a dual endorsement of "industrial collaboration + equity subscription." From the PRC to the World: An Integrated Platform for First-in-Class Peptide Drugs Micot Pharma's underlying capability lies in establishing an integrated drug R&D system that supports global First-in-Class drugs from molecular design to clinical translation, further extending into an end-to-end global industrial chain platform spanning discovery, development, and commercialization. This positions the company not merely as a single-pipeline Chapter 18A company, but as a peptide innovative drug enterprise with platform-based innovation, global regulatory registration, international clinical execution, and industrialization capabilities. The early success of MT1013 and XTL6001 underscores Micot Pharma's ability to "select the right targets and understand the disease" and demonstrates the coordinated execution capacity of its end-to-end platform. The IPO raised approximately HK$1.067 billion, with proceeds primarily allocated to core pipeline clinical development and registration, commercialization rollout, development of product candidates, and R&D of the peptide technology platform. With a huge potential market, strong backing from government and strategic shareholders, and ample IPO funding, Micot Pharma has established a solid foundation to progressively realize its clinical and commercial value over the coming years, while acting as a key driving force for Chinese peptide innovation to expand globally. -End- 25/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 25/06/2026 / 17:42 UTC+8 On June 18, 2026, the 2026 International Automotive and Supply Chain Expo (Hong Kong), also known as Auto HK, opened at AsiaWorld-Expo. During the expo, Dongfeng Motor Corporation, a Chinese automaker, held a brand strategy launch event, officially unveiling its " Skyward Sailing Plan " global expansion ambition aimed at strengthening its presence in Hong Kong and other right-hand-drive markets worldwide. Among those attending the event were Dr. Wingco Lo, a member of the National Committee of the Chinese People's Political Consultative Conference, chief chairman of the Auto HK organizing committee and president of the Chinese Manufacturers' Association of Hong Kong; Yu Xiao, chairman of the Auto HK organizing committee and vice chairman and president of the Hong Kong Chinese Enterprises Association; Tam Yiu-chung, secretary-general of the Hong Kong Coalition and vice chairman of the Chinese Association of Hong Kong and Macao Studies; and Liu Yan, deputy secretary-general of the China Association of Automobile Manufacturers. Dongfeng unveils "Setting Sail" global expansion strategy You Zheng, Deputy President of Dongfeng Motor Corporation, said technological innovation would remain the company's key driver for international expansion. As Hong Kong has been serving as a strategic hub for Dongfeng's development in right-hand-drive markets, it supports the brand expansion into Southeast Asia, Australia and New Zealand, the Middle East and other regions. Under its "Skyward Sailing Plan”, Dongfeng said it would focus on three technology pillars: "Tianyuan Intelligence Plan" for smart mobility, "Pure Sky Zero-Carbon Plan" for low-carbon technologies, and "All-Domain Safety" to enhance vehicle safety. Under the blueprint, Dongfeng said it would invest more than 100 billion yuan ($14.8 billion) over the next five years to implement a three-stage international expansion plan covering exporting vehicles, establishing local production, and developing overseas industrial ecosystems. The company plans to launch 55 overseas-specific vehicle models, establish 6,000 service outlets, build 10 large-scale overseas production bases with localized manufacturing accounting for 50% of output, and establish five overseas research and development centers and two overseas financial platforms. Dongfeng also aims to increase the proportion of locally hired overseas employees to 70%. By 2030, the company aims to achieve global sales of 5 million vehicles, with the share of new energy vehicles exceeding 70% and the proportion of overseas sales reaching 40%. Four-brand lineup targets right-hand-drive markets At the exhibition, Dongfeng showcased vehicles from four brands covering mass-market, smart family, premium intelligent and off-road segments. The company said its existing right-hand-drive models under the mass-market brand will remain the core of its market strategy, while development of vehicles under the three other premium brands is being accelerated. Together with its Hong Kong flagship store and supporting service network, Dongfeng said it aims to strengthen its presence in right-hand-drive markets through an integrated product and after-sales strategy. Several dedicated right-hand-drive models under the mass-market brand, including the DONGFENG 007, DONGFENG VIGO and DONGFENG BOX, have already been launched in Hong Kong. The company said sales in Hong Kong during the first quarter of 2026 provided support for its expansion in mass-market right-hand-drive segments. Development of right-hand-drive models under the Epicland, Voyah and MHero brands is also progressing, with plans to respectively expand into smart family vehicles, premium luxury vehicles and professional off-road segments. Dongfeng also said its Hong Kong flagship store has come online, offering maintenance services for right-hand-drive vehicles, localized charging solutions and tailored financing services, while supporting the expansion of its dealer network in Southeast Asia to provide integrated sales and after-sales services for right-hand-drive customers. Agreements signed to expand low-carbon initiatives During the event, Dongfeng signed several cooperation agreements related to its Hong Kong market strategy. The company’s subsidiary Dongfeng Import & Export Corporation signed an agreement with Oriental Swan Motor Group Limited, the company’s sole agent in Hong Kong, covering an order for 3,000 vehicles in the Hong Kong market for 2026. The company also announced cooperation agreements with several industry partners covering infrastructure, aviation services, retail operations and equipment services, aimed at supporting the development of smart, low-carbon mobility solutions in Hong Kong. Dongfeng said it will continue to pursue its international expansion strategy under the principle of "In Global For Global," while working with global partners to expand its presence in overseas markets. Company：China Dongfeng Motor Industry Imp. & Exp. Co., Ltd. Email: wangzhenling@dfmc.com.cn Website: www.Dongfeng-global.com 25/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 23/06/2026 / 10:15 UTC+8 HONGQI made a landmark appearance today at 2026 International Automotive Supply Chain Expo in Hong Kong, unveiling three all-new right-hand drive (RHD) electric vehicles, signaling a new phase of its global development. As China’s oldest and most prestigious premium automotive brand, HONGQI is committed to its mission of “Shaping mobility for the world” Having independently achieved breakthroughs over 1,500 core technologies, the brand has established three proprietary architectures: the Pure Electric, the Hybrid, and the Intelligent. Through this robust R&D foundation, HONGQI aims to introduce a new era of Chinese premium smart manufacturing, innovative technology, and distinct Oriental aesthetics to the world. Over the next three years, HONGQI will leverage Hong Kong as a strategic springboard to roll out over six all-new electric vehicles (EVs) to RHD markets worldwide, continually enriching its overseas portfolio. A Tailored RHD Lineup Built for Diverse Global Mobility The three RHD models showcased today feature clear market positioning, designed to complete the brand’s overseas portfolio and meet the diverse mobility needs of global consumers. HONGQI Global SUV: Positioned as a global, aesthetic, intelligent, all-electric SUV, this model blends Eastern and Western design philosophies. It features striking “Starry Night” headlights and an exclusive Celadon Green finish for an overwhelming visual impact. The cabin utilizes a perfectly symmetrical mid-layout balanced design, seamlessly adapting to both urban commuting and family road trips. Built to stringent global safety standards, the HONGQI Global SUV is slated to enter the Hong Kong market in the fourth quarter of 2026. HONGQI EHS5: Tailored for driving enthusiasts, the HONGQI EHS5 is a high-performance all-electric SUV equipped with an intelligent all-wheel-drive (AWD) system. It delivers exceptional 0-100 km/h acceleration combined with professional-grade chassis tuning for superior handling. HONGQI E-HS9 RHD: Serving as the luxury flagship all-electric SUV, the E-HS9 RHD inherits HONGQI’s design philosophy of Taihe-inspired proportions alongside oriental ritual aesthetics. The interior is meticulously crafted with luxurious materials and a full suite of premium audio-visual and comfort features. Powered by a 120kWh battery pack and a dual-motor powertrain, it delivers worry-free range across all terrains. Top-tier passenger safety is guaranteed by a robust 9H cage body structure and an IP68-rated waterproof battery. Officially launched for the Hong Kong market at today's event, the E-HS9 promises an elegant, reliable, and peerless mobility experience. Sharing the spotlight at the event is a milestone E-HS9 prototype. This endurance-tested vehicle recently completed a 35-day, 10,000-kilometer journey across six countries and regions along the Silk Road. This extensive real-world trial serves as a powerful testament to the vehicle's unwavering reliability, providing strong quality assurance ahead of its Hong Kong rollout. New Hong Kong Experience Center to Set Luxury Benchmarks Expanding its retail footprint, the dedicated HONGQI Hong Kong Experience Center is scheduled to officially open on July 1 in Taikoo Shing, Hong Kong Island. The facility will introduce the comprehensive HONGQI CARE 365 service program, offering an end-to-end premium customer experience—spanning vehicle browsing, test drives, delivery, and lifetime maintenance. Through exceptional products and attentive service, HONGQI aims to elevate the international image of Chinese automakers and establish a new benchmark in the global luxury auto sector. From the cultural exchanges of the ancient Silk Road to this new voyage along the shores of Hong Kong, HONGQI remains steadfast in its vision: to redefine global luxury automotive standards through the Eastern philosophy of harmony and coexistence. As the brand accelerates its global journey alongside international partners, it continues to deliver Oriental elegance and uncompromising courtesy to drivers around the world. Media Contact Company: Hongqi AutoEmail: wangmiao@faw.com.cn 23/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 22/06/2026 / 10:36 UTC+8 LONDON, United Kingdom - June 22, 2026 - (SeaPRwire) - The Buddyhood Publishing has introduced an impact-first model for independent publishing in the UK, placing social purpose at the centre of how it develops, produces, and sells books. Founded in 2025 by Harleen and Andrew Ahluwalia-Cook, The Buddyhood Publishing focuses on children's books, middle-grade fiction, and young adult titles that address topics such as mental health, emotional resilience, online safety, and social responsibility. The company links each title to causes connected to the themes explored in the book, with a portion of proceeds supporting charitable work in those areas. The publisher said its model is built around the idea that books can serve both readers and communities. Alongside its editorial focus, The Buddyhood Publishing works with UK-based production partners, including printers in Glasgow, as part of its wider focus on keeping value within British supply chains. The company's early activity has included support for charities, as well as the distribution of books and resources to schools, hospitals, and community initiatives. Its publishing programme is shaped in part by engagement with schools, charities, and young audiences, with the aim of producing books that reflect issues affecting children and young people today. Harleen said: "We have always wanted The Buddyhood Publishing to be about more than selling books. For us, the aim is to create stories that empower, educate, and entertain, while building a model where each title can contribute to a wider social purpose." The company said this impact-first structure is intended to align commercial activity with charitable giving and socially relevant storytelling. Rather than treating purpose as a separate campaign, The Buddyhood Publishing has made it part of its core business model. The publisher's catalogue includes books across a range of age groups and formats, with a focus on stories that connect with the lived experiences of young readers. Themes explored in its titles include emotional wellbeing, digital life, and the social pressures affecting children and teenagers. The company said this direction reflects growing interest in books that offer both strong storytelling and meaningful subject matter. Andrew emphasises: "We believe publishing can create value in more than one way. That means telling stories that matter to young people, working with partners who share our values, and making sure the success of a book can support something beyond the book itself." The Buddyhood Publishing said its UK-based production model is another part of that structure. By working with British suppliers, the company aims to support local businesses and maintain a clear value chain across the production process. The publisher's work has already received industry recognition. In its first year, The Buddyhood Publishing was shortlisted for the Independent Publishing Awards 2026 in both newcomer and sustainability categories, reflecting early attention on its business model and publishing programme. The company said it sees the impact-first model as part of a broader response to changing expectations among readers, families, educators, and retailers. With growing attention on values, transparency, and relevance, The Buddyhood Publishing is positioning its books as titles that connect storytelling with practical social outcomes. The Buddyhood Publishing said it will continue to expand its publishing programme while maintaining its focus on purpose-led titles, UK production, and charitable links connected to each release. About The Buddyhood PublishingThe Buddyhood Publishing is a UK independent publisher founded in 2025. The company publishes children's books, middle-grade fiction, and young adult titles with a focus on themes such as mental health, emotional resilience, online safety, and social responsibility. Its impact-first model links each title to charitable causes connected to the themes explored in the story, while its UK-based production model supports domestic supply chain partners. Contact Information Brand: The Buddyhood Publishing Contact: Hannah Copson Email: team@thebuddyhood.com Website: www.thebuddyhood.com 22/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 18/06/2026 / 17:14 UTC+8 (Hong Kong, June 18, 2026) – AGTech Holdings Limited (Stock Code: 8279 on the Stock Exchange of Hong Kong Limited, hereinafter referred to as “AGTech” or the “Company”) announced today that it has formally submitted an application to the Stock Exchange in relation to the proposed transfer of listing of the Company's Shares from GEM to the Main Board pursuant to Chapter 9B of the Main Board Listing Rules[1]. The Board believes that, as the Company continues to expand its business scale and deepen its strategic diversification, the Proposed Transfer of Listing would provide a more appropriate listing platform for the Company’s next phase of growth. In particular, taking into account the Company’s diverse business operations in areas such as digital payments, banking, wealth management, cross-border settlement and regional financial collaboration, the Board believes that a listing on the Main Board would enhance brand recognition of the Company as a comprehensive financial technology group, strengthen its engagement with users, merchants, financial institutions, business partners and investors, and support the Company’s ability to pursue commercial opportunities in its current market positioning. Meanwhile, the Main Board offers a broader investor base and higher market recognition, which will help enhance investor awareness of and confidence in the Company, expand the Company’s coverage among institutional investors and in international capital markets, further optimize its shareholder base and investor structure, improve the liquidity of its shares, and provide greater flexibility for the Company’s long-term development. On the basis of the foregoing, the Proposed Transfer of Listing is beneficial to the future growth and development of the Company and is in the overall interests of the Company and the Shareholders. As a member of Alibaba Group, AGTech Holdings is committed to becoming a leading global comprehensive financial technology group. It focuses on diversified services including full-scale financial services, commerce enablement and local consumer services, while actively expanding into emerging business areas such as innovative technology services for the gold and precious metals trading, thereby developing the capability to provide “end-to-end, all-round financial services” across diverse scenarios. In 2022, the company completed the acquisition of Macau Pass Holding Ltd. and its subsidiaries, significantly expanding its footprint into the payment sector. In 2024, it completed the attainment of the controlling stake in Ant Bank (Macau) Limited, further solidifying its “payment + finance” platform foundation. Currently, AGTech is actively broadening its innovative financial business. In early 2026, the company reached a collaboration with the Hong Kong Gold Exchange (HKGX) to design, develop and maintain a secure and stable electronic trading, clearing, and settlement platform. This initiative aims to support Hong Kong's development as an international gold trading center and drive the digital transformation of the gold and precious metals market. For the year ended March 31, 2026, AGTech recorded a total revenue of approximately HK$760 million, representing a year-on-year growth of about 23.7%, reflecting a continuous expansion in its operational scale. Notably, the full-scale banking services delivered outstanding performance, generating about HK$225 million in revenue during the year, a substantial year-on-year surge of approximately 232.7%. The rising proportion of high-growth businesses and the further optimization of the revenue structure demonstrate that the company's overall strategic transformation over the past few years has begun to materialize. Looking ahead, AGTech will continue to deepen the development of its fintech ecosystem, and capitalize on development opportunities within the Guangdong-Hong Kong-Macao Greater Bay Area and international markets to steadily advance its global business footprint. -End- ABOUT THE GROUP AGTech, as a member of the Alibaba Group, was incorporated in Bermuda and its Shares are listed on GEM (Stock Code: 8279). The Company is included as a constituent stock in the MSCI World Micro Cap Index. As a comprehensive financial technology group, AGTech’s core businesses are broadly divided into four principal categories: (1) Full-scale financial services: (i) Digital payment services: (a) mCard (b) MPay (c) Merchants acquiring services 1 (ii) Full-scale banking services: (a) Digital banking services for individuals and SMEs 2 (b) Wealth management services 3 (2) Commerce enablement and local consumer services: lifestyle, culture and entertainment, marketing technical services for merchants and e-commerce platform (3) Innovative technology services for the gold and precious metals trading (4) Lottery services 4 1 This service also includes the business line previously presented under “payment‑related hardware supply”. 2 This service includes deposits, loans, transfers and cross-border remittances, cross-border e-commerce/supply chain financing, etc. 3 This service encompasses the business lines previously presented under “internet securities investment, account services, insurance agency services, and customer self-service banking outlet”. 4 This service includes lottery hardware sales, lottery offline distribution, as well as other integrated services. For more details, please visit www.agtech.com [1] Shareholders and potential investors should be aware that the Proposed Transfer of Listing is subject to, among others, the granting of relevant approval by the Stock Exchange. There is no assurance that approval and permission will be obtained from the Stock Exchange for the Proposed Transfer of Listing. Accordingly, the Proposed Transfer of Listing may or may not proceed. Shareholders and potential investors are advised to exercise caution when dealing in the Shares. 18/06/2026 Dissemination of a Marketing Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 17/06/2026 / 10:57 UTC+8 On June 17, as A-share listed company, LINGYI iTECH (GUANGDONG) COMPANY (“LY iTECH”) formally disclosed its Hong Kong IPO prospectus, Sunny Optical Capital Limited (“Sunny Optical Capital”), the wholly‑owned investment platform of Sunny Optical Technology (Group) Company Limited, made its first public appearance. As one of the cornerstone investors in LY iTECH’s Hong Kong listing, Sunny Optical Capital subscribed US$20 million, and this move marks the official launch of Sunny Optical Technology’s new strategic phase of “dual‑drive” growth — combining product value and capital value. As the first landmark investment project since the establishment of Sunny Optical Capital, this cornerstone investment is not only a financial deployment, but also a critical move by Sunny Optical Technology to deepen industrial synergy and build its “circle of friends” in the capital market. It is understood that Sunny Optical Capital is an investment platform established by Sunny Optical Technology in Hong Kong to implement its new five‑year strategic plan, focusing on capital operations. It does not target short‑term financial returns, but instead concentrates on pre‑IPO investments, cornerstone investments, and overseas mergers and acquisitions, using capital as a link to systematically build Sunny Optical Technology’s “circle of friends” in the capital market. Industry professionals have paid close attention to the establishment of Sunny Optical Capital, believing that this platform will become a strategic fulcrum for Sunny Optical Technology to command the industrial high ground, ensure supply chain security, and incubate a new growth curve. 17/06/2026 Dissemination of a Marketing Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 17/06/2026 / 09:49 UTC+8 In the Hong Kong equity market, micro-cap stocks are routinely sidelined by institutional investors due to liquidity constraints and perceived single-business risks. However, Okura Holdings Limited (1655.HK)—a traditional operator of Japanese pachinko parlors in Nagasaki Prefecture—is quietly positioning itself at the confluence of global regulatory tailwinds. The company is orchestrating a textbook valuation re-rating, driven by the regulatory optionality within Japan's emerging casino sector. From a fundamental perspective, consensus opinion remains tethered to Okura’s mature core pachinko operations. Yet, value investors will recognize that this legacy portfolio anchors the enterprise with a resilient valuation floor. Following extensive consolidation within the Japanese gaming landscape, Okura has preserved a dominant regional footprint and robust cash generation in its home market. The stock currently trades at severely depressed multiples, with a trailing price-to-earnings (P/E) ratio around 2x and a price-to-book (P/B) ratio of approximately 0.3x. Amid macroeconomic volatility, this extreme valuation discount provides a formidable margin of safety, yielding a classic asymmetric risk-reward profile. The true catalyst, however, resides in the embedded option value of Japan’s secondary casino licenses (Integrated Resort, or IR concessions). Following the central government's approval of the MGM Resorts and Orix consortium in Osaka, Japan’s gaming ecosystem has entered a secular expansionary phase. Under current statutory frameworks, two additional casino licenses remain unallocated, and Tokyo is slated to reopen the competitive bidding window in 2027. Given that Nagasaki was a prime contender in the initial licensing tranche, local authorities are widely anticipated to mount a renewed bid. As the premier homegrown entertainment operator in Nagasaki, Okura commands deep-seated political networks and coveted commercial real estate assets, rendering it an indispensable local partner for multinational gaming concessionaires. Should the 2027 licensing momentum accelerate, Okura stands as a pure-play, micro-cap proxy primed for upward multiple expansion. While the upcoming casino bidding represents a compelling medium-term regulatory call option, management’s recent capital allocation strategy has delivered an immediate alpha generator. According to regulatory filings, Okura deployed its idle cash reserves into a pre-IPO vehicle targeting SpaceX(SPCX), securing Class A common stock at $126 per share just ahead of its Nasdaq debut. With SpaceX stock now surging past the $200 mark post-listing, Okura has locked in a staggering gain of over 58% on paper, capturing substantial balance sheet upside in a matter of days. While the absolute dollar amount is nominal relative to SpaceX's market capitalization, it represents a highly accretive asset appreciation for a company of Okura's scale. The transaction successfully breaks the valuation ceiling of a legacy entertainment stock, overlaying a premium global aerospace narrative onto its corporate profile without overshadowing its core gaming catalysts. Viewed holistically, Okura Holdings’ strategic posture reflects a calculated play on structural regulatory inflection points. The deeply discounted core business provides robust downside protection, while the 2027 Japan casino license reopening serves as a powerful catalyst to unlock balance sheet optimization. For sophisticated capital allocators hunting for deep value paired with asymmetric upside, this overlooked gaming play is emerging as a compelling dark horse. 17/06/2026 Dissemination of a Marketing Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 15/06/2026 / 20:24 UTC+8 （Hong Kong, June 15, 2026）— AGTech Holdings Limited (“AGTech”or“the Group”, HKEX Stock Code: 8279) today announced its final results for the year ended march 31, 2026. FINANCIAL HIGHLIGHTS Revenue of the Group for the year ended March 31, 2026 amounted to approximately HK$760.5 million (Year ended March 31, 2025: approximately HK$615.0 million), representing an increase of approximately 23.7% compared to the year ended March 31, 2025. For the year ended March 31, 2026, revenue contributions were mainly derived from the following businesses: Digital payment and related businesses (including commerce enablement and local consumer services and payment-related hardware sales and lease income) There was an overall increase in revenue by approximately HK$16.6 million to approximately HK$323.8 million for the year ended March 31, 2026, mainly due to the increase in transaction payment volume (TPV) driven by the rise in inbound tourists in Macau and increase in local consumption through digital payment benefiting from the consumption promotion campaign such as the “Community Consumption Grand Prize 2025”. Furthermore, the revenue from commerce enablement and local consumer services increased by approximately 85.2% to approximately HK$27.7 million for the year ended March 31, 2026, mainly driven by its continuous strategic initiatives provided to the local consumers and merchants. Full-scale banking business There was an overall increase in revenue by approximately HK$157.7 million to approximately HK$225.5 million for the year ended March 31, 2026, mainly due to (i) the consolidation of financial statements of ABM (Ant Bank (Macao) Limited) into those of the Group for the entire year, compared with only about seven months for the year ended March 31, 2025 following the completion of the Group’s acquisition of a controlling stake in ABM on September 2, 2024; (ii) the Group’s continuous innovations have led to a significant growth in both customer base and customer deposits. Lottery business There was an overall decrease in revenue by approximately HK$28.7 million to approximately HK$211.2 million for the year ended March 31, 2026, mainly due to the decrease in revenue from sales of lottery hardware by approximately HK$35.5 million as a result of the decrease in lottery hardware tenders awards and deliveries and partially offset by the increase in revenue from the provision of lottery offline distribution services by approximately HK$6.8 million. The loss for the year ended March 31, 2026 was approximately HK$54.2 million (for the year ended March 31, 2025: approximately HK$98.6 million). The overall decrease in loss for the year is primarily attributable to: (i) no fair value changes were recognized for the year ended March 31, 2026 on the convertible term loan facilities in the maximum amount of INR1,319.4 million (equivalent to approximately HK$137.3 million) previously provided by the Group to, and fully utilized by, its 45%-owned joint venture company in India, First Games Technology Private Limited (“JV”), as compared to a fair value loss of approximately HK$70.9 million for the year ended March 31, 2025. During the year ended March 31, 2026, the Group has entered into a mutual agreement with the JV for the termination of the Facilities and a gain on derecognition of approximately HK$3.5 million was recognized by the Group; and (ii) the decrease in finance income by approximately HK$14.0 million to approximately HK$30.3 million (for the year ended March 31, 2025: approximately HK$44.3 million) mainly due to the decrease in market interest rates for the year ended March 31, 2026 as compared to the corresponding period in 2025. BUSINESS REVIEW During the reporting period, the proportion of the Group's high-growth businesses continued to rise, optimizing the revenue structure and driving steady improvement across key operating indicators. These trends signal an accelerated shift from a "lottery + payment" provider to an “integrated fintech platform”. Core business segments are now working in synergy: alongside our leading position in digital payments, our full-scale banking services are growing rapidly, while innovative technology services for the gold and precious metals trading have opened up new growth horizons. Overall, the initial results of the strategic transformation are beginning to materialize. The Group’s fintech businesses have evolved into a digital ecosystem (as outlined in the diagram above). Full-scale Financial Services Leveraging the deep synergy between Macau Pass and ABM, the Group is comprehensively building a fintech ecosystem that encompasses both high-frequency payments and full-scale financial services. Digital Payment Services The Group's digital payment business is primarily conducted through Macau Pass, which is one of the leading digital payment service providers in Macau, principally engaged in mCard, MPay and merchants acquiring services. mCard is a contactless payment card widely used by Macau residents and visitors. There are currently over 6.0 million mCards in issuance, supporting local public transportation and over 30,000 consumption points across Macau. During the reporting period, mCard continuously deepened its regional connectivity strategies, in collaboration with cities across the Chinese Mainland, including Zhuhai and Wuhan, we launched the “Zhuhai-Macao Public Transport Card”,“Wuhan-Macau Intercity Card” , etc. At the same time, we subsequently launched a series of creative products, including the NBA China Games mCard, the Capybara MINI mCard, moving beyond the traditional transit card role and further promoting brand rejuvenation. The cross-border payment service was also optimized. With the addition of a top-up service option for Alipay users on September 26, 2025, it has significantly enhanced the convenience of payment and travel for tourists from Chinese Mainland in Macau. MPay is one of the most widely used e-wallets among Macau residents，with approximately 1.73 million registered users. It has become a Super App that covers dining, transportation, tourism, entertainment, online and offline shopping, finance and cross-border services and payments. On the local ecosystem front, MPay has continuously deepened its local digital ecosystem by launching the MPay Tap! Function and extending the“Amap Ride-Hailing” mini-app to the local Macau market. Meanwhile, its cross-border payment ecosystem has shown strong growth momentum. During the reporting period, the number of cross-border payment transactions and the total transaction payment volume increased by approximately 43% and approximately 44% year-on-year, respectively. In terms of international payment networks, MPay now supports users in about 60 countries and region. To facilitate northbound consumption and travel by Macau residents, it has been continuously enriching its "Cross-Border Zone" ecosystem, which now integrates approximately 90 popular mini-apps in the Chinese Mainland, including Amap Ride-Hailing, Meituan Takeout, and transit QR code of Guangzhou Metro. We are also one of the leading acquirers in Macau. Our acquiring services support travellers from over 10 overseas countries and region to use their home country/region’s e-wallets in Macau. During the reporting period, Macau Pass pioneered the introduction of innovative payment solutions exemplified by Alipay Tap! and MPay Tap! Features, and deepened scenario-based cooperation with local business partners including Sands China. As of March 31, 2026, Alipay’s innovative payment method Alipay Tap! has covered over 8,000 merchant stores across Macau. Full-scale Banking Services The Group's banking business is conducted by ABM (the “Bank”). ABM is a local full-scale bank in Macau holding a full banking licensce, providing comprehensive financial services including convenient account opening, payment and spending, global remittance, savings and wealth management (including insurance agency), and credit services to individuals and SMEs users. During the reporting period, the Bank continues to improve the full range of product services system including deposits, loans, remittances, currency exchange, and investments. The Bank also advanced its offline expansion strategy, opening its first self-service outlet in October 2025 and will consider setting up other wealth management centers in the future, gradually forming a comprehensive banking service model that integrates online digital capabilities with an offline service network. In addition, we established an online insurance payment zone and reached an agency cooperation agreement with HSBC insurance products, further expanding the product portfolio. In terms of customer management, the bank also focuses on youngster and endeavors to reach users with differentiated services through online operations and offline outlets, forming a distinct customer service advantages over conventional banks. During the reporting period, the Bank achieved growth in both customer base and fund size, with the total number of individual customers increasing by approximately 76% year-on-year and total deposits growing by approximately 235%. Commerce Enablement and Local Consumer Services Leveraging MPay’s large user base and payment traffic, together with the synergistic advantages of the mCoin and mPass platforms, the Group continues to convert online traffic into offline commercial value,empowering local business development. Leveraging the synergies of the MPay payment ecosystem, mPass provides Macau residents and tourists with a comprehensive lifestyle and travel service platform offering a wide range of services across dining, shopping, entertainment, events and high-end customised travel experiences. During the reporting period, mPass in collaboration with the Macau Economic and Technological Development Bureau and Damai, launched the “Concert + Community Consumption Benefits” campaign, effectively directing concert-goers to communities such as the Zona de Aterros do Porto Exterior (“ZAPE”,新口岸填海區). Meanwhile, it collaborated with MPay to support government and commercial initiatives to boost consumption, such as the “National Games Boost • Community Consumption Grand Prize”, and the “POP MART Macao Citywalk” (與POP MART漫游澳門), effectively increasing users’ spending activity. Additionally, during the reporting period, mPass has also supported over 130 performances and events in Macau. mCoin activates the points economy: mCoin is MPay’s exclusive points and benefits platform. During the reporting period, the mCoin platform has newly launched an mCoin gift feature. As of March 31, 2026, the cumulative volume of mCoins transferred via the gift function reached approximately 1 billion mCoins. The platform also launched the “Value Buy” (抵到爆) mCoins redemption program, collaborating with high-quality merchants to provide exclusive products, thereby achieving a mutually beneficial promotion of advantages for users and increased traffic for merchants. During the reporting period, the Group continued to deepen partnerships with product partners, leveraging digital technology to empower local business upgrades and the development of smart cities. In addition to collaborating with Alipay and Sands China to launch the Alipay Tap! Service at Sands Resorts Macao, we also collaborated with Amap to launch the “Cool Travel Festival” (清涼出行節), the “Amap Street Stars -Macao Authentic Delicacies Ranking” and the “Macao City Life Support Program”. These initiatives not only provided comprehensive support for Macau’s local merchants and empower local small and medium-sized merchants in their digital transformation and service capability upgrade, but also contributed to the growth of community economies. Furthermore, we successively established strategic cooperation with Huawei Services (Hong Kong) Limited, China Telecom (Macau) Limited, China Arts and Entertainment Group Ltd., Damai Entertainment and the Galaxy Macau™ integrated resort. These collaborations aim to explore opportunities in areas such as digital service innovation, smart city development, and cultural content growth. Innovative Technology Services for the Gold and Precious Metals Trading As part of the Group’s innovative financial strategy, the Group will design, develop, and maintain a secure and reliable electronic trading, clearing and settlement platform for HKGX and its market participants. The platform will integrate spot, futures, digital gold, B2C transactions, clearing and settlement center, over-the-counter (OTC) trading, membership management and a unified risk control system. It will support both offshore and onshore Renminbi, featuring multi-currency pricing and settlement capabilities, multilingual support, and an open and compatible architectural design. The platform aims to enhance market efficiency, connect global investors, and help strengthen Hong Kong’s position as an international gold hub. Lottery Services The lottery business maintained steady growth. The Group is one of the leading suppliers of lottery terminals in China. During the reporting period, the Group won 12 lottery hardware tenders to supply lottery terminals to the Sports Lottery Administration Centers in a number of provinces and municipalities, including Hubei, Hainan, Shandong, Tianjin, Guizhou, Jiangsu, Shaanxi, Guangdong, Fujian and Chongqing. BUSINESS OUTLOOK The Group is dedicated to becoming a leading global comprehensive financial technology group. With full-scale financial services, commerce enablement and local consumer services, and innovative technology services for the gold and precious metals trading as its core, the Group aims to build a comprehensive digital ecosystem and create a new paradigm for modern financial services. The Group will continue to strengthen its “payment + finance + technology” infrastructure. By offering full-scale banking services, e-wallet, acquiring services, mCard, multipurpose digital payment system and other services, we will continuously deepen the development of service scenarios to enhance the payment experience for local residents and tourists, while striving to promote mobile payment and inclusive finance in Macau, and contribute to its smart city transformation. Leveraging its ecosystem collaboration with Alibaba Group and Ant Group, and capitalizing on the global connectivity advantages of Alipay+, the Group will further provide support for more electronic payment tools from overseas countries and regions to facilitate the consumption of visitors to Macau, and achieve cross-border payment facilitation. Additionally, the Group will fully leverage its strengths in content and channels to provide Macau merchants with increased online exposure and digital upgrade solutions, empowering them to achieve digital transformation, thereby driving Macau’s local economic development and supporting the construction of a “World Centre of Tourism and Leisure”. On this basis, the Group will connect scenarios and resources of the ecosystem with payment plus full-scale financial services, leverage internal business synergies to continue to expand its diversified business portfolio. We will also further explore additional commercialization opportunities across the digital payment ecosystem, e-commerce, digital media and entertainment, and cultural entertainment markets, continuously enriching the value proposition of our digital ecosystem. Looking ahead to the Web3.0 era, the Group has been actively expanding into innovative finance. We are currently accelerating the deep integration of gold and precious metals trading with cutting-edge technologies, striving to build an innovative trading platform with international competitiveness. Moving forward, we will continue to deepen our strategic layout. By leveraging technology-driven initiatives and ecosystem co-creation, we aim to constantly expand the application boundaries of precious metals trading technology, injecting new vitality and momentum into the financial market development of the Guangdong-Hong Kong-Macao Greater Bay Area and beyond. With roots in Macau and sights set on the global stage, the Group will continue to invest resources to improve its technological infrastructure. Focused on user needs, we will continuously deepen service scenarios, expand our global financial service footprint, seek innovative business opportunities and continue delivering on our commitment to provide long-term sustainable growth for the shareholders. -End- ABOUT THE GROUP AGTech, as a member of the Alibaba Group, was incorporated in Bermuda and its Shares are listed on GEM (Stock Code: 8279). The Company is included as a constituent stock in the MSCI World Micro Cap Index. As a comprehensive financial technology group, AGTech’s core businesses are broadly divided into four principal categories: (1) Full-scale financial services: (i) Digital payment services: (a) mCard (b) MPay (c) Merchants acquiring services 1 (ii) Full-scale banking services: (a) Digital banking services for individuals and SMEs 2 (b) Wealth management services 3 (2) Commerce enablement and local consumer services: lifestyle, culture and entertainment, marketing technical services for merchants and e-commerce platform (3) Innovative technology services for the gold and precious metals trading (4) Lottery services 4 1 This service also includes the business line previously presented under “payment‑related hardware supply”. 2 This service includes deposits, loans, transfers and cross-border remittances, cross-border e-commerce/supply chain financing, etc. 3 This service encompasses the business lines previously presented under “internet securities investment, account services, insurance agency services, and customer self-service banking outlet”. 4 This service includes lottery hardware sales, lottery offline distribution, as well as other integrated services. For more details, please visit www.agtech.com 15/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS Newswire / 09/06/2026 / 16:00 UTC+8 (9 June 2026, Hong Kong) Waton Financial Limited Unveils MoTA: An AI-Native Investment Team Operating System and Agent Marketplace That Lets Anyone Build, Manage, and Command Their Own Professional Investment Research Team Waton Financial Limited today unveiled MoTA (Manager of Trading Agents), an AI-native investment team operating system and Agent marketplace that redefines what AI can do for investors. MoTA is not a stock-picking chatbot or a black-box trading bot. It is a platform designed to let users build, manage, and command their own team of specialized AI Agents across the full investment workflow — from portfolio definition to trade execution. The Problem Professional investment research has always required a team: factor researchers, fundamental analysts, technical analysts, risk managers, portfolio constructors, and trade execution officers. Each role demands specialized talent and expensive infrastructure. For individual investors and small teams, assembling such a capability has been cost-prohibitive — until now. The Solution MoTA transforms the user from a passive consumer of AI signals into an active leader of an AI-powered investment team. Its four integrated modules work together to deliver a seamless, end-to-end experience. First, Talents — the Agent Marketplace. Users browse, compare, and hire specialized AI Agents by role. Each Agent is purpose-built for a specific investment function — fundamental analysis, technical analysis, risk management, trade execution, and more. Agents can be swapped and composed as strategies evolve. Second, Team — composing your investment team. Users assemble multiple Agents into a structured team. Analysts feed research inputs, the Portfolio Manager evaluates and writes memos, the Risk Manager reviews exposure, and the Trader validates routing. The human user retains final sign-off authority at every stage. Third, Portfolio — the portfolio cockpit. A real-time overview of holdings, assets, P&L, risk, and exposure. Users see exactly what is moving across positions, where risk sits, and where returns originate — all in one unified view. Fourth, Decision — the Decision Center. Every Agent-generated suggestion surfaces in the Decision Center with full context: source Agent, signal, reasoning, and current status. Users can click into the full workflow or execution path, compare competing analyses, and manage an actionable queue of decisions. Every recommendation is structured, traceable, and auditable. These four modules connect in a continuous workflow: Portfolio to Decision to Team to Trade. Why MoTA Is Different Traditional AI investing tools offer a single AI chat box, scattered research answers, black-box signals, no role separation, and AI value that is hard to measure. Reviews are tied to AI silos. MoTA provides a multi-Agent investment team, a connected Portfolio-to-Trade workflow, an auditable Decision Center, dedicated Analyst and PM and Risk and Trader roles in coordination, unified metrics such as ROI and win rate and cost per run and override rate, and a unified path for portfolio, decisions, Agents, and trades. The Vision Behind MoTA Waton Financial Limited's mission with MoTA is clear: to make professional-grade multi-agent investing tools more accessible, more transparent, and more user-controlled. MoTA does not replace human judgment — it amplifies it. The platform frees users from the burden of being a full-stack investment expert and elevates them to a higher role: the builder, manager, and decision-maker of their own AI investment team. As AI moves from content generation into workflow execution, investing — inherently a multi-role, multi-step, multi-constraint process — is a natural fit for this transformation. MoTA is designed to bridge the gap between what AI can do and what the investment workflow actually needs. About MoTA MoTA (Manager of Trading Agents) is Waton Financial Limited's flagship AI-native investment team operating system and marketplace for specialized investing Agents. It enables users to create fully customizable investment teams, assign specialized AI Agents to each role, and receive structured, traceable, and auditable investment suggestions across the entire Portfolio-to-Trade workflow. About Waton Financial Limited Waton Financial Limited is a publicly listed financial services and technology company that designs, owns, and operates the MoTA platform. Waton is committed to building AI-native infrastructure for investment teams and making professional-grade multi-agent investing tools accessible to a broader audience. Welcome to MoTA. Welcome to the new era of investing. Media Contact Email: ir@watonfinancial.com Website: https://wtf.us Explore MoTA: https://mota.ai Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those expressed or implied. This is not investment advice. Past performance does not guarantee future results. 09/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com View original content: EQS News

EQS via SeaPRwire.com / 12/06/2026 / 15:02 UTC+8 Shanghai - 12 Jun 2026 - The clinical datasets presented at ASCO 2026 further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a next-generation immuno-oncology (I/O) backbone therapy. I. Trispecific Design Rationale and Differentiated Advantages 1. Greater Potential for Long-Term Survival Benefit vs. PD-1+VEGF Combinations, with Low CTLA-4-Related Toxicity and Favorable Tolerability CS2009 was designed to restore T-cell effector function, remodel the tumor microenvironment (TME), and enhance T-cell priming via simultaneous targeting of PD-1, VEGF, and CTLA-4, aiming to generate deeper and more durable anti-tumor immune responses. • Differentiated CTLA-4 Design: The CTLA-4 component is engineered to avoid excessive activation of peripheral CTLA-4 single-positive T cells, thereby reducing systemic immune toxicity. Combined with VEGF-mediated tumor enrichment, this design preserves the immune-stimulatory benefit of CTLA-4 blockade while substantially improving tolerability. Clinical data has demonstrated that CTLA-4-related toxicities with CS2009 are notably lower than that of conventional CTLA-4 antibody regimens, with immune-related adverse events (irAEs) approaching incidence typically seen with PD-1 monotherapy or PD-1-based bispecific antibodies. • Advantage of Continuous Dosing: Unlike conventional CTLA-4 antibodies, which are often limited to two or three doses due to tolerability concerns, CS2009 can be administered continuously, therefore fully leveraging the CTLA-4 mechanism—not only initiating and enhancing existing anti-tumor T-cell responses but also continuously priming new T-cell clones against newly released tumor antigens throughout treatment. This ongoing expansion of the anti-tumor T-cell repertoire, combined with CS2009’s favorable tolerability, is expected to drive more durable immune responses, prolong clinical benefit, and ultimately improve overall survival. • Pharmacodynamic Validation: Dose-dependent upregulation in ICOS, a recognized pharmacodynamic marker of CTLA-4 pathway activation and T-cell activation, were observed. The ICOS elevation suggests that CS2009 continuously promotes T-cell priming and clonal expansion, validating the biological activity of its CTLA-4 module and providing biological basis for long-term anti-tumor activity. Industry challenge: Historically, most anti-VEGF plus PD-(L)1 regimens have primarily improved progression-free survival (PFS), while overall survival (OS) benefits remains highly uncertain. By incorporating a CTLA-4 mechanism, CS2009 aims to break through this limitation. 2. Low VEGF-Related Toxicity Supporting More Adequate Treatment Exposure and Sustained Clinical Benefit Pharmacodynamic data demonstrated: • Circulating VEGF levels have declined continuously following dosing, and no clear rebound has been observed after up to 147 days of follow-up. This pattern differs from results reported with traditional anti-VEGF antibodies or PD-1/VEGF bispecifics, potentially due to CS2009’s enrichment in the tumor microenvironment and CTLA-4-mediated internalization and clearance of VEGF-antibody complexes. This may reduce reflux of VEGF and its antibody-bound complexes into the peripheral circulation, thereby lowering VEGF-related systemic toxicities such as hypertension and proteinuria. Clinical data demonstrated: • The incidence of Grade ≥3 VEGF-related treatment-related adverse events (TRAEs) is only 5.1%, notably lower than reported rates for certain VEGF-based bispecifics. Industry challenge: VEGF is both a critical efficacy driver and a major source of toxicity in combination therapies. Achieving an optimal balance between efficacy and tolerability, particularly in elderly and high-risk patients, remains a longstanding, unresolved challenge in the VEGF field. 3. Consistent Activity Observed Across Multiple “Cold” Tumors, Highlighting the Value of the CTLA-4 Module and the Trispecific Mechanism Promising anti-tumor activity has been observed in several traditionally immunotherapy-insensitive tumor types, including: Immunotherapy-resistant non-small cell lung cancer (NSCLC), pMMR/MSS metastatic colorectal cancer (mCRC), Soft tissue sarcoma (STS), Non-clear cell renal cell carcinoma (nccRCC). These findings suggest that the combined blockade of PD-1 and CTLA-4, together with VEGF modulation, may enhance T-cell priming, broaden T-cell clonal diversity, promote durable immune memory, and improve T-cell infiltration within the TME—extending immune responsiveness to tumors that were previously I/O-insensitive. The consistent efficacy signals across multiple cold tumors support the ability of CS2009’s PD-1, CTLA-4 and VEGF synergism to reshape the immunosuppressive TME, expand the I/O-benefiting population, and demonstrate the potential to transcend the efficacy boundaries of traditional PD-1 inhibitors and PD-1/VEGF bispecifics. Industry challenge: Effective immunotherapy options remain limited for cold tumors. PD-1 plus CTLA-4 blockade is still one of the most widely recognized strategies for enhancing immunotherapy responsiveness. 4. Consistent Benefit Observed Across Squamous and Non-Squamous NSCLC • Across multiple NSCLC treatment settings, comparable response rates were observed in both squamous and non-squamous patients. CS2009 is showing a trend of consistent benefit across histological subtypes, indicating that its mechanism may not depend on a particular pathologic type and may cover a broader population of NSCLC patients, enhancing the probability of success in future global registrational trials. Industry challenge: Notable differences in efficacy between squamous and non-squamous NSCLC often limit the label expansion and commercial potential of certain products. II. Favorable Safety Profile with Notably Lower VEGF-Related Toxicity Compared with Bispecifics Safety data from the ongoing Phase I study in a mixed tumor population (N=118): • Grade ≥3 TRAE incidence: 24.6%; • Grade ≥3 irAE incidence: 12.7%; • Grade ≥3 VEGF-related TRAE incidence: 5.1%. Focusing on the later-line NSCLC cohort (n=57): • Grade ≥3 TRAE rate: 19.3%; • Grade ≥3 irAE rate: 12.3%; • VEGF-related Grade ≥3 TRAE rate: 5.3%; • Consistent with the safety profile of the overall heavily pretreated mixed-tumor population. Overall: • CTLA-4-related toxicity appears very well controlled. • No new or unexpected safety signals have been identified. • The overall safety profile is comparable to that of PD-1/VEGF bispecific antibodies, while VEGF-related toxicity appears substantially lower. This safety profile provides an important foundation for long-term dosing and future global registrational development. III. Efficacy in “Cold” Tumors Demonstrates Differentiated Clinical Value CS2009 has demonstrated meaningful clinical activity across multiple “cold” tumors, highlighting the differentiated mechanism. 1. Monotherapy in Later-Line pMMR/MSS mCRC • All enrolled patients had heavily pretreated, refractory CRC, including cases with BRAF mutations and right-sided tumors. • CS2009 monotherapy achieved an ORR of 25% and a DCR of 87.5%. Given that ORR in later-line colorectal cancer are typically in the single digits, these results demonstrate clinically meaningful anti-tumor activity. More importantly, efficacy signals emerging in a typical cold-tumor population further supports the differentiated value of the CTLA-4 module. 2. Combination with XELOX in First-Line pMMR/MSS mCRC • The study did not select patients by tumor sidedness, molecular subtype, or liver metastasis; the enrolled population better reflects real-world clinical practice. • To date, all six patients have experienced tumor shrinkage, and three patients achieved a partial response (PR) at their first efficacy assessment. • ORR was 66.7%, and DCR was 100%. Although the sample size remains small, highly consistent early efficacy signals have already been observed, providing positive support for subsequent global registrational development. The Company plans to expand the cohort to approximately 40 patients to generate a more comprehensive proof-of-concept (POC) dataset for upcoming discussions with the global regulatory authorities including the U.S. Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA) on a Phase III global registrational clinical trial. 3. Other “Cold” Tumors • Monotherapy in Later-line Soft Tissue Sarcoma (STS): ORR 33.3%, DCR 66.7%; • Monotherapy in Later-line non-clear cell renal cell carcinoma (nccRCC): ORR 33.3%, DCR 100%;. • Durable responses have also been observed. Notably, the first patient enrolled in Phase I (an Australian female) has experienced sustained tumor shrinkage of more than 40% over 12 months. IV. NSCLC: Multi-Dimensional Data Support Global Registrational Development Dimension 1: Later-Line NSCLC Monotherapy (Pretreated with IO, Chemotherapy, ADCs, or Bispecifics) • Overall ORR in the 30 mg/kg cohort: 24% (squamous 25%, non-squamous 23.1%, consistent benefit); DCR 60%; • In second-line NSCLC (30 mg/kg, post IO + chemotherapy): ORR improved to 30.8%, DCR 84.6%. • In such post-PD-(L)1 patient populations, standard-of-care ORRs are generally low, thus CS2009 has demonstrated competitive single-agent activity. Additional observations include: • 6-month duration-of-response (DOR) rate exceeded 80% (i.e., more than 80% of responders remained in response at 6 months); • Depth of response has continued to deepen over time; • DOR data are still maturing. Dimension 2: Later-Line NSCLC in Combination with Docetaxel • All six evaluable patients experienced tumor shrinkage, resulting in an ORR of 66.7% and a DCR of 100%. Although the sample size is currently small, these results are already very competitive within this class of studies. The company plans to expand the cohort to approximately 20 patients to inform subsequent registrational decisions. Dimension 3: First-Line NSCLC Monotherapy (PD-L1 TPS ≥50%) • Among 16 patients, ORR was 81.3% and DCR was 100%; • Squamous ORR 87.5%, non-squamous ORR 75%, consistent benefit; • Earlier data (March 2026) showed 9 PRs out of 10 patients; among the 6 newly enrolled patients, 4 achieved a PR at their first tumor assessment, bringing the total number of PRs observed to 13; • No responding patients have experienced rapid disease progression, and patients have shown deepening responses over time. While cross-trial comparisons have limitations, CS2009’s single-agent ORR in first-line NSCLC (PD-L1 TPS ≥50%) has reached a best-in-class range among comparable studies globally, demonstrating highly competitive clinical potential. Note: Data in the PD-L1 1%–49% population continue to mature. Dimension 4: First-Line NSCLC in Combination with Chemotherapy (Squamous, PD-L1 Low or Negative) • Among 8 squamous patients enrolled to date, 7 patients have PD-L1 ≤1% (low/negative), and 1 patient has PD-L1 ≤5% (low expression); median age is 70 years; • ORR was 75% and DCR was 100%; among PD-L1-negative patients, ORR reached 100%; Particularly noteworthy: • A 100% response rate was observed among PD-L1-negative patients; • Encouraging efficacy was also observed in elderly patients. Although longer follow-up is required, positive and consistent early efficacy signals are evident. Note: Enrollment is ongoing in the first-line all-comer squamous NSCLC (Chemo Combo) and first-line non-squamous NSCLC (Chemo Combo) cohorts. Data will be disclosed subsequently. V. Global Registration Strategy CS2009 is advancing through a global multi-regional clinical development pathway. • Rapid enrollment supports timely data package generation and regulatory engagement. • Registrational studies will not be conducted in a single country; all key registrational studies will be global multi-regional clinical trials (MRCTs) using current international standard-of-care comparators (pembrolizumab / pembrolizumab + chemotherapy / bevacizumab + chemotherapy). The trial designs and timelines are independent of data readouts from other bispecific/trispecific competitors, giving CS2009 a self-determined development advantage. - October 2026: Discuss the Phase III global registrational clinical trial protocol for first-line NSCLC + chemotherapy (vs. pembrolizumab + chemotherapy) . - Q4 2026: Discuss the Phase III global registrational clinical trial protocol for first-line mCRC + chemotherapy (vs. bevacizumab + chemotherapy) . - Early 2027: Discuss the Phase III global registrational clinical trial protocol for second-line NSCLC (CS2009 + docetaxel vs. docetaxel) and first-line NSCLC monotherapy (head-to-head vs. pembrolizumab) . 20–60 patients of POC data are expected per indication. The company has already established a clinical, CMC (Chemistry, Manufacturing and Controls) and operational system that supports global development, laying the groundwork for subsequent global multi-center Phase III MRCTs . VI. Key Catalysts in 2026 • Late August 2026: Interim results update featuring more mature post-ASCO clinical data. • Around October 2026: FDA discussion regarding the Phase III global registrational clinical trial protocol for first-line NSCLC + chemotherapy. • Q4 2026: FDA discussion regarding Phase III global registrational clinical trial protocol for first-line CRC + chemotherapy. • Q4 2026: ESMO Congress – clinical data updates for CRC, NSCLC, and other indications. • End of 2026: Initiation of the first-wave global Phase III MRCTs. Importantly, all pivotal studies are benchmarked against current global standard-of-care comparators, without dependency on competitors’ development progress. VII. Business Development Progress In-depth discussions are ongoing with multiple multinational pharmaceutical companies (MNCs). Key areas of partner interest include: trispecific antibody design rationale, safety profile, clinical data in NSCLC and CRC, global registration strategy. As data continue to mature and the global development advances, the differentiated value of CS2009 is gaining increasingly broad and strong recognition. VIII. Management Confidence and Capital Markets Initiatives 1. Share Purchases by Management and the Board: Management and the Board believe that the recent share price volatility has significantly deviated from the Company’s fundamental progress. Management and Board members have expressed their confidence in the long-term value of CS2009 and the Company’s growth prospects by increasing their shareholdings. 2. Anticipated inclusion in the Hong Kong Stock Connect Scheme Management expressed a positive expectation that the Company will be included in the Stock Connect scheme at the September 2026 adjustment window. IX. Key Takeaway The ASCO 2026 data mark CS2009’s transition from mechanism validation to the clinical proof-of-concept (POC) stage. Its differentiated trispecific design not only delivers an excellent safety profile, but also consistently generates clinically meaningful efficacy signals and durable responses across a range of traditional I/O-cold tumors and lung cancer populations. As the key CRC and NSCLC programs move toward global registrational development, CS2009 is steadily emerging as a next-generation I/O backbone agent with significant potential. About CStone CStone (HKEX: 2616), established in late 2015, is an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas. Dedicated to addressing patients’ unmet medical needs in China and globally, the Company has made significant strides since its inception. To date, the Company has successfully launched 4 innovative drugs and secured approvals for 21 new drug applications covering 9 indications. The company’s pipeline is balanced by 16 promising candidates, featuring antibody-drug conjugates (ADCs), multispecific antibodies, immunotherapies and precision medicines. CStone also prides itself on a management team with comprehensive experiences and capabilities that span the entire drug development spectrum, from preclinical and translational research to clinical development, drug manufacturing, business development, and commercialization. For more information about CStone, please visit: www.cstonepharma.com. IR contact: ir@cstonepharma.com PR contact: pr@cstonepharma.com Forward-looking statements The forward-looking statements made in this article only relate to events or information as of the date when the statements are made in this article. Except as required by law, we undertake no obligation to update or publicly revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. All statements in this article are made on the date of publication of this article and may change due to future developments. Disclaimer: only for communication and scientific use by medical and health professionals, it is not intended for promotional purposes. 12/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 12/06/2026 / 09:50 UTC+8 Chicago, Illinois - June 12, 2026 - (SeaPRwire) - Lossdog, a new financial technology platform co-founded by Tom Sosnoff and Scott Sheridan, has officially launched in the United States with a mission to give working professionals access to the same quality of compensation data that employers have long used in salary negotiations. The platform offers a single, calculated dollar figure representing a user's professional market worth, expressed as annual salary. Sosnoff and Sheridan previously co-founded thinkorswim, an online brokerage specializing in options trading that was acquired by TD Ameritrade in 2009 for approximately $750 million. The two then co-founded tastytrade, a retail brokerage and financial media network acquired by IG Group in 2021 for $1.1 billion. Lossdog marks their third major fintech venture. The platform works by analyzing a user's resume against real labor market records, including government wage data, to produce a precise professional valuation. Lossdog also includes a portfolio optimization tool that evaluates a user's investment holdings and calculates the lifetime dollar value of underperformance relative to an industry baseline. Research published by Lossdog in early 2026 found that a professional starting at $75,000 per year could leave approximately $3.9 million in uncaptured nominal earnings over a 30-year career, a figure the company attributes to structural information asymmetry in wage negotiation. A follow-up report published in March 2026 found the gap to be significantly wider for female professionals. "Most professionals leave seven figures on the table over their careers because they're negotiating blind," said Jeff Joseph, Chief Strategist at Lossdog. "We built the first AI platform that reads your resume, analyzes your skills and experience against real data, and tells you what you're actually worth down to the dollar." To mark the platform's launch, Lossdog is offering free first-year subscriptions, valued at $100 each, to its first 50,000 registered users. Those users will also share in a $1 million cryptocurrency pool, with individual awards ranging from $50 for the earliest registrants to $10 for those in later waitlist positions. The company has reported more than 25,000 waitlist registrations. Lossdog operates in a space adjacent to platforms such as LinkedIn, Glassdoor, and Payscale, but distinguishes its product by generating an individual-specific figure rather than aggregated salary ranges. The platform currently serves users in the United States. "After 40-plus years on the trading side of the business world, we are about to take on a bigger challenge," Sheridan wrote publicly ahead of the launch. About Lossdog Lossdog is a Chicago-based financial technology company co-founded by Tom Sosnoff and Scott Sheridan. The company offers a subscription-based platform that uses artificial intelligence and government labor market data to calculate the precise professional market value of individual workers and to evaluate the performance of their investment portfolios. Lossdog is currently available to users in the United States. Contact Information Brand: Lossdog Contact: Jeff Joseph Email: jeff.joseph@lossdog.com Website: https://lossdog.com 12/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 11/06/2026 / 18:43 UTC+8 Results Highlights Chow Tai Fook Jewellery delivered strong FY2026 performance on the back of successful brand transformation, achieving high-quality earnings growth against macro uncertainties and significant gold price volatility. Revenue grew 5.3% to HK$94,398 million, underpinned by steady growth from design-led and higher-margin iconic collections. The Group achieved an operating profit of HK$18,850 million (+27.8% YoY) and a record high profit attributable to shareholders of HK$9,004 million (+52.2% YoY). Gross profit margin expanded to 32.3%, supported by higher gold prices and increased contribution from the retail business and design-led jewellery. Operating profit margin expanded 360bps to a five-year high level of 20.0% driven by strong business performance and continued disciplined cost management. Return on Equity ("ROE") increased to 28.4%, which represented a sustained improvement against our 5-year historical average of 20.5%. The Group opened its first global flagship store in Hong Kong in February 2026, alongside newly designed stores across the Chinese Mainland and key international markets, while expanding into luxury lifestyle categories. The Board has proposed a final dividend of HK$0.45 per share, bringing the full-year total to HK$0.67 per share, a payout ratio of 73.4%, reflecting our commitment to sustained shareholder returns. Financial Summary For the year ended 31 March 2026HK$ million 2025HK$ million YoY Change Revenue 94,398 89,656 +5.3% Gross profit 30,500 26,455 +15.3% Gross profit margin 32.3% 29.5% +280 bps Operating profit(1) 18,850 14,746 +27.8% Operating profit margin 20.0% 16.4% +360 bps Profit attributable to shareholders of the Company 9,004 5,916 +52.2% Earnings per share Basic (HK$) 0.91 0.59 +53.7% Diluted (HK$) 0.90 0.59 +52.5% Full year dividend per share(2) (HK$) 0.67 0.52 N/A (1) Aggregate of gross profit and other income, less selling and distribution costs and general and administrative expenses (2) The payout ratio for FY2026 approximated 73.4% (Hong Kong, China, 11 June 2026) Chow Tai Fook Jewellery Group Limited (“Chow Tai Fook Jewellery Group”, the “Group” or the “Company”; SEHK stock code: 1929), today announces its annual results for the year ended 31 March 2026 ("FY2026"). Record Results Underscore the Continued Success of Brand Transformation The Group demonstrated strong resilience as revenue grew 5.3% to HK$94,398 million in a year marked by macroeconomic uncertainty and significant gold price volatility. Gross profit margin of 32.3% was up 280bps, driven by the surge in gold price and a higher contribution from the design-led and higher- margin iconic collections, successfully launched since 2024. Operating profit grew 27.8% to HK$18,850 million and profit attributable to shareholders grew 52.2% to a record high HK$9,004 million. Operating profit margin of 20.0% was up 360 bps to a five-year high level. The Group’s Return on Equity ("ROE") increased to 28.4%, which represented a sustained improvement against our 5-year historical average of 20.5%. The Board has proposed a final dividend of HK$0.45 per share, bringing the dividend per share for the year to HK$0.67, a full-year payout ratio of 73.4%. The strong performance was powered by a customer centric approach driven by three key levers of growth: (1) Redefining Chinese luxury globally, (2) Rejuvenating portfolio and operational efficiency and (3) Reimagining new horizons. Dr. Henry Cheng, Chairman of Chow Tai Fook Jewellery Group, said, “We are committed to investing boldly in our brand – elevating desirability, forging deeper emotional connection with customers, and expanding our global resonance through immersive retail experience, exquisite craftsmanship, compelling storytelling and digital engagement that blends our rich heritage and cultural artistry with contemporary lifestyle.” Commenting on the annual results, Ms. Sonia Cheng, Vice-chairman of Chow Tai Fook Jewellery Group, said, “We are delighted that the Group achieved record high results and high-quality earnings, validating the success of our brand transformation. As a leading global Chinese luxury group, Chow Tai Fook is charting a course to bring Chinese aesthetics, craftsmanship, and heritage storytelling to the world stage while setting a new benchmark for the industry. Redefining Chinese Luxury Globally The global luxury landscape has been dominated by Western culture. Our ambition is to redefine Chinese luxury globally, showcasing the contemporary Chinese culture, innovation and exquisite craftsmanship to the world. The successful launch of our signature collection – DAWN Collection, has clearly demonstrated Chow Tai Fook’s innovation and creativity, being the first jewellery brand to blend Chinese aesthetics with modern craftsmanship. Since its launch in April 2026 till the end of May 2026, DAWN Collection has delivered remarkable initial results, with Retail Sales Value (“RSV”) of over HK$500 million, outperforming the debut of some of the signature collections to date. Furthermore, more than 20% of customers purchasing this Collection were new to us in the Chinese Mainland, Hong Kong and Macao, underscoring the effectiveness of our signature collections in driving new customer acquisition. During the year, we unveiled our first High Jewellery Collection, “Timeless Harmony”, championing Eastern aesthetics through culturally rooted, world‑class craftsmanship and expanding the brand’s presence in the global high jewellery segment. In March 2026, we appointed David Tse as Global Creative Director, bringing deep luxury expertise from his tenure as Creative Director at Hermès in China, to lead our global storytelling and deepen brand desirability. Blending heritage with contemporary designs, our signature collections continue to resonate with the growing base of culturally conscious consumers. The Rouge Collection, Joie Collection and Chow Tai Fook Palace Museum Collection sustained strong sales momentum in FY2026, contributing close to HK$10 billion to our RSV, while the iconic HUÁ Collection contributed HK$43 billion to our RSV. Rejuvenating Portfolio and Operational Efficiency In February 2026, the Group opened its first global flagship store on Canton Road in Tsim Sha Tsui, Hong Kong, marking a significant milestone in its brand transformation journey. The approximately 10,000-square-foot flagship is the Group’s largest store across Hong Kong and Macao, showcasing the brand’s nearly century-long legacy, craftsmanship and creativity through it’s “Heritage Pavilion” and diverse offerings. The flagship offers consumers an elevated retail experience that reflects our evolving ambition as the leading global Chinese luxury group. As of FY2026, we had a total of 8 newly designed luxury-format stores in prime locations in the Mainland. These stores delivered significantly higher productivity, which was approximately 8 to 10 times the average Same Store Sales (“SSS”). These newly designed stores also had a substantially higher contribution from fixed-price jewellery. We also selectively opened stores in high-footfall locations, backed by enhanced visual merchandising, optimised product mix and elevated retail experience. As a result, the average monthly RSV of new stores aged less than two years reached approximately HK$1.6 million, up 57% YoY. In view of the success of the newly designed luxury-format stores, we plan to expand its network in the Mainland from the current 8 stores to 50 by FY2030. In the Mainland, SSS increased by 6.9% in FY2026, supported by our ongoing brand transformation initiatives and continued store optimisation. In Hong Kong and Macao, consumer demand strengthened notably post Mainland VAT reform on gold trading, with SSS rising 16.8% in FY2026. SSS growth in Hong Kong was 13.3% and Macao was 29.4% for the year. During the year, the Group also advanced digitalisation and launched our in-house AI Agent platform, deploying over 12 agents across functions such as visual merchandising, the GenAI jewellery creative centre, and AI live streaming, to drive operational efficiency and enhance customer engagement. Reimagining New Horizons The Group’s FY2030 ambition is to double the RSV of our international operations compared to FY2026; and to have an international footprint of over 100 stores. In line with our ambition, the Group expanded the Chow Tai Fook universe into new geographies, channels, product categories, and experiences that resonate with the constantly evolving lifestyle and aspirations of customers in FY2026. With the ambition to reshape global luxury and further strengthen our brand influence among global audiences, newly designed luxury-format stores were launched at Jewel Changi Airport in Singapore, Siam Paragon in Bangkok, and Westfield Sydney in Australia – marking our first entry into Oceania. This brings the total number of CHOW TAI FOOK JEWELLERY POS in Other Markets to 63. In FY2027, we will open further newly designed luxury-format stores across Southeast Asia and North America, while exploring opportunities in the Middle East in the next two years. As the first global Chinese jewellery brand to enter the luxury lifestyle arena, the new luxury home-décor line “Chow Tai Fook Home” brings craftsmanship, cultural heritage and attention to detail to refined home décor and functional art, including tableware collections developed in collaboration with renowned French porcelain house Bernardaud, where Western craftsmanship meets Chinese cultural heritage and gold artistry. Together with CTF Accessories which covers hair adornments, gold medallions and watch strap accessories, the new lifestyle offers will capture diverse market segments, broaden our customer base and create synergies with our core jewellery business. In FY2026, we continued to collaborate proactively with renowned IPs to reach new audiences. Our Black Myth Collection received overwhelming market response, with a significantly higher male mix than the Group average. Meanwhile, collaborations with Disney, Chiikawa and the NBA attracted new loyalty members, which accounted for 35%–55% of these IP collaborations’ customers, with a significant percentage of younger generations. HEARTS ON FIRE, a member of the Group, has continued its transformation into a modern global luxury diamond jewellery brand within the Group. During the year, HEARTS ON FIRE delivered resilient performance with its iconic INSIDE/OUT Collection contributing to 13% of the brand’s global revenue. The brand also expanded its retail presence in Asia with five new luxury retail locations, strengthening visibility in key luxury markets. Business Outlook The strong financial and operational performance highlights the success of our brand transformation strategy and paves the way for further growth. We are now entering the definitive phase of our multi-year transformation journey to our centenary in 2029, accelerating the pace and ensuring the precision of our full-scale strategic execution in FY2027 and beyond. Our sharpened focus is on elevating brand desirability, enriching the retail experience, and strengthening product differentiation. Despite continuing external market volatility and macroeconomic uncertainty, we remain cautiously optimistic in the markets where we operate. We are firmly committed to our brand transformation journey – redefining Chinese luxury globally, rejuvenating portfolio and operational efficiency and reimagining new horizons. We will continue to rigorously uphold financial discipline in cost and capital management, driving high-quality growth, sustainable earnings and returns for our shareholders. FY2030 Ambitions As we approach our centenary, we envision a Chow Tai Fook universe where jewellery seamlessly intertwines with the lifestyle of our customers – enriching their appreciation of cultural heritage, artistry, and craftsmanship. We see luxury as a universal language that transcends borders and cultures, where jewellery and lifestyle come together to express a shared vision of beauty, elegance, and creativity. Looking ahead to FY2030, we have set out the following ambitious targets: Financial performance: We aim to achieve above-market revenue growth, and sustain a high ROE of above 25% by FY2030; Store network evolution: We target to complete the full renovation and elevation of our POS portfolio by FY2030, delivering a cohesive and distinctive retail experience across all locations. In parallel, we plan to expand our network of newly designed luxury-format stores in the Mainland from the current 8 stores to 50 by FY2030; International expansion: We aim to double the RSV of our international operations compared to FY2026; and to have an international footprint of over 100 stores. Sustainability: We will target a 50% reduction in Greenhouse Gas emissions by FY2030, using FY2024, the first year of our brand transformation journey, as the base year. ### Chow Tai Fook Jewellery Group Limited Since its founding in 1929, CHOW TAI FOOK, the flagship brand of Chow Tai Fook Jewellery Group, has been celebrated for its bold designs and meticulous attention to detail. Our commitment to innovation and craftsmanship has made us synonymous with excellence, value, and authenticity. As the global Chinese luxury group, we blend contemporary designs with traditional techniques to create timeless pieces. Each collection reflects our customers' stories and lives, celebrating their special moments. We aspire to inspire and captivate generations to come, weaving the story of CHOW TAI FOOK into their own. Our brand portfolio includes the iconic CHOW TAI FOOK flagship brand, HEARTS ON FIRE, ENZO, and MONOLOGUE, offering a wide variety of products that also includes an expanding range of cutting-edge IP collaborations. With over 5,000 stores worldwide, we offer a seamless client journey across all touchpoints that includes a network across China as well as a growing number of global locations. Chow Tai Fook Jewellery Group Limited (SEHK: 1929) has been listed on the Main Board of the Hong Kong Stock Exchange since December 2011. We are committed to delivering sustainable long-term value for our stakeholders by continually enhancing earnings quality and driving higher value growth. Media Enquiries: Chow Tai Fook Jewellery Group Limited Haide Ng Associate Director, Corporate Communications Tel: (852) 3115 4402 Email: haideng@chowtaifook.com 11/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 09/06/2026 / 16:00 UTC+8 (9 June 2026, Hong Kong) Waton Financial Limited Unveils MoTA: An AI-Native Investment Team Operating System and Agent Marketplace That Lets Anyone Build, Manage, and Command Their Own Professional Investment Research Team Waton Financial Limited today unveiled MoTA (Manager of Trading Agents), an AI-native investment team operating system and Agent marketplace that redefines what AI can do for investors. MoTA is not a stock-picking chatbot or a black-box trading bot. It is a platform designed to let users build, manage, and command their own team of specialized AI Agents across the full investment workflow — from portfolio definition to trade execution. The Problem Professional investment research has always required a team: factor researchers, fundamental analysts, technical analysts, risk managers, portfolio constructors, and trade execution officers. Each role demands specialized talent and expensive infrastructure. For individual investors and small teams, assembling such a capability has been cost-prohibitive — until now. The Solution MoTA transforms the user from a passive consumer of AI signals into an active leader of an AI-powered investment team. Its four integrated modules work together to deliver a seamless, end-to-end experience. First, Talents — the Agent Marketplace. Users browse, compare, and hire specialized AI Agents by role. Each Agent is purpose-built for a specific investment function — fundamental analysis, technical analysis, risk management, trade execution, and more. Agents can be swapped and composed as strategies evolve. Second, Team — composing your investment team. Users assemble multiple Agents into a structured team. Analysts feed research inputs, the Portfolio Manager evaluates and writes memos, the Risk Manager reviews exposure, and the Trader validates routing. The human user retains final sign-off authority at every stage. Third, Portfolio — the portfolio cockpit. A real-time overview of holdings, assets, P&L, risk, and exposure. Users see exactly what is moving across positions, where risk sits, and where returns originate — all in one unified view. Fourth, Decision — the Decision Center. Every Agent-generated suggestion surfaces in the Decision Center with full context: source Agent, signal, reasoning, and current status. Users can click into the full workflow or execution path, compare competing analyses, and manage an actionable queue of decisions. Every recommendation is structured, traceable, and auditable. These four modules connect in a continuous workflow: Portfolio to Decision to Team to Trade. Why MoTA Is Different Traditional AI investing tools offer a single AI chat box, scattered research answers, black-box signals, no role separation, and AI value that is hard to measure. Reviews are tied to AI silos. MoTA provides a multi-Agent investment team, a connected Portfolio-to-Trade workflow, an auditable Decision Center, dedicated Analyst and PM and Risk and Trader roles in coordination, unified metrics such as ROI and win rate and cost per run and override rate, and a unified path for portfolio, decisions, Agents, and trades. The Vision Behind MoTA Waton Financial Limited's mission with MoTA is clear: to make professional-grade multi-agent investing tools more accessible, more transparent, and more user-controlled. MoTA does not replace human judgment — it amplifies it. The platform frees users from the burden of being a full-stack investment expert and elevates them to a higher role: the builder, manager, and decision-maker of their own AI investment team. As AI moves from content generation into workflow execution, investing — inherently a multi-role, multi-step, multi-constraint process — is a natural fit for this transformation. MoTA is designed to bridge the gap between what AI can do and what the investment workflow actually needs. About MoTA MoTA (Manager of Trading Agents) is Waton Financial Limited's flagship AI-native investment team operating system and marketplace for specialized investing Agents. It enables users to create fully customizable investment teams, assign specialized AI Agents to each role, and receive structured, traceable, and auditable investment suggestions across the entire Portfolio-to-Trade workflow. About Waton Financial Limited Waton Financial Limited is a publicly listed financial services and technology company that designs, owns, and operates the MoTA platform. Waton is committed to building AI-native infrastructure for investment teams and making professional-grade multi-agent investing tools accessible to a broader audience. Welcome to MoTA. Welcome to the new era of investing. Media Contact Email: ir@watonfinancial.com Website: https://wtf.us Explore MoTA: https://mota.ai Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those expressed or implied. This is not investment advice. Past performance does not guarantee future results. 09/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 08/06/2026 / 10:13 UTC+8 On June 5, 2026, C.banner (01028.HK) announced that it will obtain controlling interests in Benyuan Zhishu, a leading domestic AI data service provider, through equity acquisition and new share subscription. Benyuan Zhishu will be consolidated into the Group’s financial statements, marking the formation of a dual-core business structure comprising “footwear+ Artificial Intelligence data”. Why data? As public data is gradually digested by large models, the critical bottleneck in AI is shifting from “whose model is bigger” to “who can continuously provide harder, more authentic, high-quality data.” Computing power can be purchased, algorithms can be replicated, but this particular task cannot be bought or expedited. In 2025, Meta invested in Scale AI at a valuation of approximately $29 billion, marking a market revaluation of this insight. The scarcity of Benyuan Zhishu lies in its position and profitability. Founded in 2015, it sits upstream in the AI industry chain and is one of the few domestic suppliers that possess comprehensive data service capabilities, including large models, world models, and embodied intelligence. It serves top-tier large model manufacturers, leading internet platforms, and eminent embodied intelligence enterprises, acting as an exclusive supplier in several high-value data categories. Its revenue in 2025 was approximately 156.2 million yuan, with a net profit of 11.1 million yuan after tax, and the first five months of 2026 have shown strong revenue growth. In an AI industry largely reliant on burning money, a data company equipped with real orders and already profitable is indeed rare. The design of this transaction also demonstrates ingenuity: it is funded entirely with the Group’s internal resources. C.banner’s footwear business generates solid cash flow and maintains a net cash position. Proceeds from the new share subscription will be invested into capacity expansion and R&D, while the founding team will retain equity holdings. Upon completion of the transaction, Benyuan Zhishu will retain its independent brand, independent operations, and data segregation. C.banner will not develop models or compete with Benyuan Zhishu’s clients, allowing industry competitors to continue using the same neutral supplier with confidence. The management of C.banner stated: “We believe that high-quality data is one of the most critical and scarce infrastructures in the era of artificial intelligence. This transaction allows the Group to enter this rapidly growing sector while maintaining a stable foundation in the consumer industry. We look forward to working with Benyuan Zhishu to continuously provide 'data fuel' of high quality to China's AI industry, creating sustainable long-term value for our shareholders under the dual-core business framework.” 08/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 04/06/2026 / 19:30 UTC+8 [Hong Kong – 4 June 2026] Newborn Town Inc., a leading global social entertainment company (Newborn Town or the company, stock code: 09911.HK) is pleased to announced that it has cancelled a total of 5,174,000 shares repurchased between 27 April and 29 May 2026, representing an aggregate repurchase consideration of approximately HK$45.32 million. Prior in March 2026, Newborn Town announced a share repurchase plan of approximately HK$300 million to be carried out over the next two years. According to the announcement, following this cancellation, the total number of issued shares will decrease from 1,413,208,391 to 1,408,034,391, and Newborn Town will no longer hold any treasury shares. The Board believes that the cancellation of the repurchased shares will enhance net asset value per share and earnings per share, which aligns with the overall interests of the Company and its shareholders. The Board will continue to review and, at its sole discretion, execute share repurchases from time to time. The Company’s continued execution of both share repurchases and share cancellations sends a clear signal of management’s confidence in Newborn Town’s long-term growth prospects, while also demonstrating its commitment to enhancing shareholder returns and improving capital efficiency. Since its inclusion in the Stock Connect in March this year, Newborn Town has seen a significant increase in trading activity, accompanied by growing participation from Southbound investors. Notably, the latest round of repurchases was conducted shortly after the release of the Company's first quarter operating update. On 22 April, Newborn Town announced its unaudited operating data for the first quarter of 2026. During the period, total revenue is expected to reach approximately RMB2,030 million to RMB2,130 million, representing a year-on-year increase of approximately 33.0% to 39.6%. Among this, revenue from social networking business increased by approximately 31.3% to 37.2% year-on-year, while revenue from innovative business surged by approximately 46.7% to 58.7%, primarily driven by the rapid expansion of its AI-powered short drama business. About Newborn Town Newborn Town has grown into a leading technology company which was listed on the Main Board of the Hong Kong Stock Exchange (HKEX) in 2019 under the stock code 9911.Committed to creating positive emotional value worldwide, Newborn Town has developed a diverse portfolio of applications in the social networking and entertainment sectors. Its social apps include MICO, YoHo, TopTop, SUGO and HeeSay, together with gaming products like Alice's Dream: Merge Games. These applications have achieved widespread acclaim, reaching over one billion users in over one hundred countries and regions.Newborn Town considers the Middle East and North Africa (MENA) region a key market and has also extended its influence in Southeast Asia, Europe, the United States, Japan, and South Korea. The company aims to become the world's largest social entertainment company. For enquiries, please contact DLK Advisory pr@dlkadvisory.com 04/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS Newswire / 03/06/2026 / 11:12 UTC+8 From Cell to System. From proven manufacturing experience to localized European support. Not only broad technology coverage, but the operational stability you can depend on. June 9–11, 2026 | Booth 1-B30 European battery manufacturers are moving beyond equipment procurement toward industrial ramp-up, where yield, uptime, process discipline, and local service capability determine long-term competitiveness. As battery manufacturing moves from pilot validation toward industrial-scale production, operational reliability is becoming increasingly critical across the industry. At The Battery Show Europe 2026, Hymson returns for its fifth consecutive year with a clear message for the European market: “How we make it reliable.” From process validation to mass production. Battery industrialization is not only about installing equipment. It requires process validation, operator training, spare parts readiness, data visibility, and continuous improvement mechanisms. Over the past five years, Hymson has continued to deepen its engagement with the European market, working alongside battery manufacturers amid evolving production demands, technology transitions, and industrial-scaling challenges. This long-term collaboration has enabled Hymson to continuously refine both its technologies and manufacturing methodologies for global battery production environments. Behind this commitment is sustained investment in innovation and engineering capability. By 2025, Hymson’s cumulative R&D investment will reach USD 86 million, with 34.47% of employees dedicated to R&D. Total operating revenue is projected to reach USD 939 million in 2026, supporting continued advancement in next-generation battery manufacturing technologies and industrial delivery capability. Mid-Section Turnkey Solutions for Scalable Manufacturing At Booth 1-B30, Hymson will present its latest Mid-Section Turnkey Solution through a comprehensive product matrix and a series of scaled technology models showcasing key manufacturing innovations, alongside extensive battery process samples demonstrating end-to-end manufacturing capabilities. The scaled equipment models on display include: Solid-State Dry-Electrode Solution Film-Forming & Calendering & Lamination Integrated Machine 390 High-Speed Cutting & Stacking Machine CT Inspection Machine for Prismatic Assembly Through these scaled technology models, Hymson will provide visitors with a more intuitive understanding of process integration, equipment architecture, and manufacturing workflow within next-generation battery production environments. Hymson will also showcase: 588Ah Cell Samples Developed for Overseas Customer Requirements 588Ah Cell Cap & Can Laser Welding Samples 40+ process samples covering electrode manufacturing, surface treatment, prismatic assembly, and stacking technologies Together, these exhibits reflect Hymson’s integrated approach to mid-section manufacturing — combining process capability, operational consistency, and scalable production performance. Reliability Starts from Cell Design For Hymson, manufacturing reliability does not begin at equipment installation or even at mass production. It begins much earlier — at the cell design and manufacturability assessment stage. To support customers throughout the entire industrialization journey, Hymson provides an integrated consulting and engineering support framework covering: Cell Design to Manufacturing Production Line Planning Mass Production Line Ramp-up Support Training A key focus within this framework is manufacturability validation before mass production. For many next-generation battery technologies, laboratory-level performance alone is not sufficient for successful industrialization. To reduce scaling risks, Hymson provides DOE (Design of Experiments) and DTM-based battery process analysis to support parameter optimization, blueprint evaluation, and manufacturability feasibility study. Through this process, Hymson helps customers establish: Optimized Process Parameters Manufacturable Battery Analysis Stable Transition from Validation to Mass Production Reduced Ramp-Up Uncertainty and Operational Risks Hymson helps customers translate validated pilot-line conditions into scalable mass-production workflows with thousands of successful delivery and implementation experiences as lessons learned, transitioning into Know-How for the customers, enabling smoother and more accurate alignment between pilot validation and large-scale production environments. This approach helps minimize the risks of industrialization while accelerating mass-production readiness. Technical discussions and in-depth solution exchanges will be available throughout the exhibition. Digitalized Operations for Long-Term Stability Beyond manufacturing equipment, Hymson will also present its End-to-End intelligent manufacturing support across equipment, logistics, and operations management This includes Hymson’s intelligent warehousing & logistics solution together with the IEMS intelligent equipment operation and maintenance system. Driven by AI algorithms and 3D visual monitoring technologies, the system enables: Digital Closed-Loop Production Real-Time Operational Visibility Intelligent Equipment Maintenance Data-Driven Production Management Dark-Factory-Oriented Operation Scenarios The system supports higher levels of automation and unmanned operation where applicable by integrating manufacturing execution, logistics coordination, and equipment operation into a unified system, Hymson helps customers improve operational transparency, production efficiency, and long-term factory stability. Spare Parts Support Built Around Operational Continuity To further strengthen production reliability, Hymson continues to enhance its global spare parts service capability. Hymson provides both original Hymson spare parts and third-party qualified industrial spare parts, tailored to customer requirements, supported by flexible supply mechanisms and predictive inventory planning. The service framework helps customers secure: Critical Spare Parts Availability Improved Price and Lead-Time Predictability Reduced Downtime Risks Lower Inventory Burden Where Applicable Optimized Total Cost of Ownership (TCO) Through data-driven spare parts forecasting and scheduled replenishment systems, Hymson aims to establish a replicable, stable after-sales support structure for long-term manufacturing operations. Advancing Reliable Battery Manufacturing from Asia to Europe Returning to The Battery Show Europe 2026 for the fifth consecutive year reflects Hymson’s long-term commitment to supporting Europe’s battery manufacturing ecosystem. From process development to intelligent factory operations, Hymson continues to combine large-scale manufacturing experience from Asia with localized industrial collaboration in Europe — helping battery manufacturers build production systems designed not only for technological advancement but also for reliable long-term operation. As Hymson has always stated, visitors are invited to discuss specific challenges such as process validation, ramp-up risk reduction, equipment OEE improvement, spare parts planning, and localized service support. Company： Hymson Laser Technology Group Co., Ltd. Contact Person: liruiyu Email: liruiyu@hymson.com Website: https://www.hymson.com 03/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com View original content: EQS News

EQS via SeaPRwire.com / 04/06/2026 / 11:06 UTC+8 Hong Kong - June 03, 2026 - (SeaPRwire) - Southeast Asia is becoming a new engine of global economic growth, with Indonesia, Thailand, and Vietnam acting as the most dazzling "vibrant troika" among them. To help global enterprises seize the dividends of the Southeast Asian market, renowned media service provider SeaPRwire (https://seaprwire.com) announced today that it has successfully and deeply tapped the local mainstream media ecosystems of Indonesia, Thailand, and Vietnam, building a PR green channel reaching hundreds of millions of consumers in Southeast Asia directly for overseas enterprises. Indonesia's demographic dividend, Thailand's consumer vitality, and Vietnam's rise in manufacturing and technology have made these three countries must-contend spots for all industries going overseas. However, the Southeast Asian region features diverse languages, scattered media forms, and vastly different religious and cultural backgrounds across countries, posing enormous challenges to the PR communication of foreign brands. SeaPRwire's localized expansion this time is precisely to solve this pain point. In Indonesia, SeaPRwire has strengthened cooperation with mainstream Indonesian-language portals in Jakarta and high-traffic social media matrices; in Thailand, the platform seamlessly interfaced with core Thai-language financial and fashion lifestyle media in Bangkok; and in Vietnam, it focused its layout on technology, venture capital, and digital media highly relied upon by the younger generation in Hanoi and Ho Chi Minh City. Through this refined localized media sinking, SeaPRwire ensures that enterprise information can be accurately and losslessly delivered to the most consumable local groups. "To explore the Southeast Asian market, 'groundedness' is the primary factor," stated SeaPRwire's Southeast Asia marketing director. "We are not just translating English drafts into local languages; we are penetrating deep into the media ecosystem capillaries of Indonesia, Thailand, and Vietnam. We hope to use news storytelling that best fits local contexts to help enterprises establish a warm and trusted local brand image." About SeaPRwire SeaPRwire is Asia’s leading AI-driven earned media management platform, purpose-built to empower PR and communications professionals. Through its flagship Branding-Insight Program, the platform connects clients to over 80,000 journalists and an influencer matrix reaching 300 million followers. Leveraging advanced AI, SeaPRwire helps users identify media targets, personalize pitches, and measure PR impact across key APAC markets, including Japan, China, Korea, and Southeast Asia. Media Contact Company: SeaPRwire Contact: Media Relations Team Email: cs@seaprwire.com Website: https://seaprwire.com 04/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 03/06/2026 / 16:58 UTC+8 On June 3, 2026, Add New Energy (stock code: 02623.HK), listed on the Main Board of the Hong Kong Stock Exchange, officially renamed as Hong Kong Gold Industry Group Limited, with its short stock name amended to Hong Kong Gold Industry Group (ticker shorthand: HK GOLD IND GP).The name change is far more than a simple rebranding. It marks the culmination of a series of strategic initiatives following the shift in controlling ownership back in October 2025. Unveiling its core development framework on June 1, Hong Kong Gold Industry Group (the “Company”) put forward the "Six Ones" development goals, laying out concrete and quantifiable metrics. The overhaul signals the Company’s full entry into the full value chain of gold, as it embarks on an ambitious journey to build a first-class gold conglomerate in Asia Pacific. Behind the Rename: Strategy First The planning and rollout of the name change have followed a strategy-first business logic.In October 2025, incoming controlling shareholders Mr. Wu Zhenxing and Ms. Wei Jiaming, alongside veteran investment banker Mr. Wu Haigan, took majority ownership of Add New Energy via HKGG Holdings Limited, securing a combined 55.6% equity stake. This ownership restructure injected new momentum into the listed Company. The new management team restructured the board of directors, assembling an 18-member board comprising industry veterans and sector specialists. In January 2026, the Company kicked off a rights issue offering existing shareholders one new share for every two held at a subscription price of HK$2.88 per share. A total of 175 million new shares were issued, generating net proceeds of approximately HK$503 million, 70% of which is earmarked explicitly for gold resource acquisitions and capital expenditure.Armed with fresh capital, the Company accelerated its global gold asset buildout at a brisk clip. In February 2026, it invested approximately A$39.5 million to subscribe for 36.57 million placement shares in Australian listed gold developer Horizon Minerals Limited (HRZ.AX), equivalent to a 9.95% holding in the developer’s issued capital, marking its entry into gold mining. A month later, the Company upped its strategic bet on the same Australian developer with a A$40.716 million acquisition of another 37.7 million HRZ.AX shares. The Company’s ownership climbed to 19.97%, cementing its position as Horizon’s single largest shareholder. HRZ.AX holds key assets in Kalgoorlie, Western Australia - one of the world’s iconic gold mining hubs. As of February 2026, HRZ.AX boasted total mineral resources of 34.32 million tonnes, translating to roughly 1.88 million troy ounces of contained gold. Its flagship Burbanks asset has substantial upside from further exploration.Concurrently, the Company pushed ahead with its precious metal footprint in China, planning a RMB221 million acquisition of a 20% equity slice in Guixi Baojia Mining via a partnership investment vehicle, granting it exposure to silver mining and processing. Having locked down this roster of tangible assets, the listed entity first announced its proposed name change on April 2, 2026, which received unanimous shareholder approval at an extraordinary general meeting held on April 29. It underscores the Company’s resolute strategic commitment and strong implementation. Decade-long Blueprint: "Six Ones" Goals and Three-Step Roadmap Released on June 3, the 2026–2035 Ten-Year Strategic Development Outline serves as the Company’s core action guideline for its full transition into gold-focused businesses. Centered on the long-term ambition of building a HK$100 billion gold industrial conglomerate, the document codifies the "Six Ones" goals spanning mining resources, production output, full value chain presence, profitability, market valuation and strategic reserves: Gold mine: To acquire 10 mid-to-large gold mines globally Resource: To build up 1,000 tonnes of proven and probable gold reserves to underpin sustainable long-term growth Production capacity: To hit annual gold output of no less than 10 tonnes, being one of the large- and mid-sized gold producers globally. Profitability: To deliver annual profits of HK$10 billion, building strong and sustainable profitability Capital market: To grow market cap beyond HK$100 billion, maximizing shareholder returns. Asset: To accumulate a 100-tonne gold strategic reserve as a strategic anchor To deliver on these ambitious goals, the Company has mapped out a robust three-step pathway:Phase 1 - Foundation Building:To secure initial acquisitions of two to three mid-to-large gold mines to add 200–300 tonnes of gold reserves. By 2027, target annual gold output of 2–3 tonnes, HK$2 billion - HK$2.5 billion in annual revenue and a market cap of HK$10 billion - HK$15 billion, cementing its market identity as a specialized gold player.Phase 2 - Rapid Expansion:To expand the global mine portfolio to another six or seven acquired assets, lifting total gold reserves to 600–700 tonnes and elevating the Company into China’s top gold miners. Aspire to annual gold output of 6–8 tonnes, annual turnover ranging from HK$5 billion - HK$6 billion and annual net profit of HK$2 billion - HK$3 billion. This phase will see the buildout of a fully functional overseas operating system with mine production across multiple time zones.Phase 3 - Industry Leadership:To fulfil all metrics under the "Six Ones" goals, achieving 1,000 tonnes of gold resource reserves and annual output above 10 tonnes. Aim to rank among the top 10 gold producers in Asia Pacific with a full value chain ecosystem, and participate in shaping industry standards. Core Competitiveness: Hong Kong’s Geographic Premium + Full Value Chain Buildout As a Hong Kong-based and mainboard-listed company, the Company leverages Hong Kong’s status as both the second largest International financial center and a global gold trading hub to develop differentiated competitive advantages.Hong Kong commands an outsized global share of cross-border gold bullion flows; total cross-border gold flow hit roughly 1,650 tonnes in 2024, accounting for 25% to 27% of all global seaborne gold trade volumes. Capitalizing on this structural edge, the Company plans to launch in-city gold refining operations targeting an incremental gross margin of US$45–US$50 per troy ounce: unlike mainland China’s 13% value-added tax on precious metals, Hong Kong’s zero-tariff regime cuts comprehensive tax costs by US$30–US$40 per ounce, while LBMA-accredited refining certification unlocks an additional US$5–US$8 per ounce premium. Additionally, Hong Kong’s sophisticated cross-border logistics network and dual-currency offshore settlement infrastructure further curtail operating costs and unlock cross-market arbitrage opportunities.From a value-chain perspective, the Company is committed to becoming a fully integrated gold conglomerate spanning upstream mining, midstream metallurgical processing, downstream trading, retail and financial services. Upstream: a targeted global M&A strategy prioritizes high-quality producing or near-production gold mines across China and its neighboring regions, Oceania, Africa and South America, following a tiered asset pipeline approach: holding multiple batches of assets across active producing mines, projects under construction and prospective reserves.Midstream: the Company intends to run Hong Kong-based refining facilities to ride on the Shenzhen Shuibei operating model - "front store plus back factory ", locking in structural cost advantages.Downstream: the Company will expand into gold trading and gold-linked financial services, rolling out gold ETF, options and other derivatives alongside gold leasing and collateralized lending products, plus digital gold solutions (e.g., similar to GoldZip). The Company also plans to set up a mining-focused investment fund targeting upstream mineral opportunities, and build its planned 100-tonne strategic gold reserves as its strategic anchor. Capital Market: Sustainable Valuation Growth Fueled by Global M&As The strategic pivot and renaming are set to drive a fundamental reshaping of the Company’s market valuation. In the gold industry, valuations globally are primarily anchored by proven mineral reserves, operating profit contribution from owned mines and future acquisition scalability. Gold players with production have an average P/E multiple of 12x, versus just 5.7x for near-production miners. The Company intends to lift the share of earnings derived from operational gold mines via sustained reserve acquisitions and capacity ramp-up, which should propel the valuation benchmark materially higher over time.Under its blueprint, the Company targets HK$100 billion in annual operating revenue and HK$10 billion in annual profits by 2035. Applying a forward P/E valuation band of 10x–15x, the implied target market cap ranges between HK$100 billion and HK$150 billion. To realize this valuation milestone, the Company has laid out a clear capital markets roadmap: fund global acquisitions of high-quality gold mineral assets via a mix of equity and bond financing, roll out employee share incentive programs and targeted business spin-offs. It targets lifting its annual dividend payout ratio to 50%–70% by 2030 and sustaining such payout levels on a sustained long-term basis, delivering attractive investment returns to shareholders while clearly communicating the Company’s strategic value to capital markets.The corporate valuations of global top-tier gold producers have consistently leapfrogged via sustained inorganic acquisitions. As illustrated by the Canadian Agnico Eagle, a two-decade string of accretive acquisitions expanded its mineral reserves and delivered substantial outperformance against peer mining stocks. Major Chinese players including Zijin Mining and Chifeng Gold have similarly unlocked robust growth via overseas resource consolidation. HK Gold Industry Group’s management team boasts an extensive track record in mineral investment and capital markets, with previous exposure spanning multiple Hong Kong-listed gold miners such as Zijin Gold International, Wanguo Gold Group, Chifeng Gold, Lingbao Gold Group, and Zhaojin Mining Industry. With ongoing strategic implementation and steady inflow of high-quality gold assets, the Company is well-positioned to replicate the growth trajectory of established leaders and scale its market cap from HK$10 billion to HK$100 billion. Closing: Ushering In a New Era for Hong Kong’s Gold Industry The renaming from Add New Energy to Hong Kong Gold Industry Group represents far more than the strategic transformation of a single listed company. It stands as a pivotal milestone for the development of Hong Kong’s broader gold industry.The Company aligns its roadmap with China’s 15th Five-Year Plan and the Hong Kong SAR government’s agenda to cement the city’s position as a global bullion trading hub. The Company has pinned its core development on the value chain of gold, and is committed to emerging as a sector leader to lead the development of Hong Kong’s gold industry. From its refreshed starting point, the Company will leverage Hong Kong’s unique geographic location and international financial center credentials to aggregate global gold mineral resources and build out its full value chain ecosystem. Steady progress against its roadmap and the Six-Ones goals is poised to transform the Company into a first-class gold conglomerate in Asia Pacific over the coming decade, delivering sustainable returns for shareholders. The Company will contribute to Hong Kong’s endeavor to build a globally influential bullion hub, ushering in a new chapter for Hong Kong’s gold industry. 03/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com